# Medical Question & Answer

**Sample ID**: 270de95c-428b-914f-04d3-c3f6dba945ef
**Dataset Index**: 243169

---

## Question

Which specific pressure injury was absent in the device group in the EIRPI trial, and what was its rate in the control group?

---

## Answer

> Let's see… What do we have here? The user is asking which specific pressure injury was absent in the device group in the EIRPI trial, and what its rate was in the control group. Let's break this down step-by-step. First, I need to think about the exact trial and intervention being discussed. Then, I should verify the primary and key secondary outcomes, especially the breakdown of endotracheal intubation-related pressure injuries by anatomical site. Next, I will extract the specific numbers for lip pressure injury in the observation (device) versus control groups. Finally, I should confirm the statistical significance and reconcile any apparent discrepancies in reported totals before concluding.

> Let me first confirm the trial identity and design so I don't misattribute data. The EIRPI trial is a dual-center randomized controlled trial comparing a self-developed endotracheal tube fixation device versus a traditional device in mechanically ventilated adults expected to need intubation for more than 48 hours, with endotracheal intubation-related pressure injury (EIRPI) as the primary outcome and site-specific injuries as secondary outcomes [^5cf4b597] [^32872992].

> Now, I need to check the specific outcomes by anatomical site. The Results section explicitly reports that lip pressure injury occurred in 0 patients in the observation (device) group versus 14 patients in the control group, with a p-value less than 0.001, indicating a statistically significant reduction with the novel device [^5cf4b597]. Hold on, I should verify the denominator and percentages to ensure I'm quoting the correct rate; with 51 patients in the observation group and 54 in the control group, 14/54 equals 25.9%, which matches the reported figure, so the control group lip pressure injury rate was 25.9% [^5cf4b597].

> Wait, let me verify the overall EIRPI context so I don't overgeneralize. The total EIRPI incidence was 7.8% with the device versus 33.3% with the traditional device, and the authors emphasize that the significant reduction was driven largely by the elimination of lip injuries, while oral–mucosal and facial injuries were similar between groups, reinforcing that the specific absence in the device group pertains to lip pressure injury [^5cf4b597] [^31ca1602].

> I should double-check for any conflicting statements about "absent" versus "reduced". Initially, I wondered if the device merely reduced rather than eliminated lip injuries, but the data are clear: lip pressure injury was 0% in the device group, which constitutes absence, not just reduction, and the between-group difference of 25.9% is statistically significant, supporting a true effect for that specific site [^5cf4b597].

> Putting this together, the specific pressure injury that was absent in the device group was lip pressure injury, and its rate in the control group was 25.9% (14/54 patients), with p < 0.001 for the comparison [^5cf4b597].

---

The specific pressure injury absent in the device group of the EIRPI trial was **lip pressure injury** [^5cf4b597], which occurred in 25.9% of the control group (14/54 patients) [^5cf4b597]. The novel fixation device **eliminated lip pressure injuries** (0/51) while significantly reducing overall endotracheal intubation-related pressure injuries from 33.3% to 7.8% (p = 0.001) [^5cf4b597].

---

## Specific pressure injury absent in the device group

In the EIRPI trial, the **lip pressure injury** was the specific pressure injury that did not occur in the device group [^5cf4b597]. This injury is a localized tissue damage to the lips caused by sustained pressure, friction, or shear from endotracheal tube fixation devices [^notfound].

---

## Incidence of lip pressure injury in the control group

In the control group, **lip pressure injury occurred in 25.9% of patients** (14/54) [^5cf4b597]. This high incidence underscores the vulnerability of the lip tissue to pressure-related damage from traditional endotracheal tube fixation devices.

---

## Comparison of lip pressure injury incidence between groups

| **Group** | **Incidence of lip pressure injury** |
|-|-|
| Device group | 0% (0/51 patients) |
| Control group | 25.9% (14/54 patients) |

---

The difference in incidence between the two groups was statistically significant (p < 0.001), indicating that the novel device effectively prevented lip pressure injuries [^5cf4b597].

---

## Clinical implications of the findings

The absence of lip pressure injuries in the device group has **important clinical implications**:

- **Patient comfort and safety**: Lip pressure injuries can cause significant pain, discomfort, and potential infection risk. Preventing these injuries enhances patient comfort and safety during mechanical ventilation [^notfound].

- **Healthcare resource utilization**: Preventing lip pressure injuries may reduce the need for additional interventions, dressings, and treatments, thereby decreasing healthcare resource utilization and associated costs.

- **Clinical practice guidelines**: The findings suggest that the novel fixation device could be incorporated into clinical practice guidelines for endotracheal tube fixation, particularly for patients requiring prolonged mechanical ventilation [^notfound].

---

## Mechanisms underlying the absence of lip pressure injury in the device group

The novel fixation device likely prevents lip pressure injury through several mechanisms:

- **Redistribution of pressure**: The device design redistributes pressure away from the lips, minimizing sustained pressure on vulnerable lip tissue [^aee423b6].

- **Silicone padding and dressings**: The device incorporates silicone padding and dressings that reduce friction and shear, further preventing tissue damage [^31ca1602].

- **Secure and stable fixation**: The device provides secure fixation of the endotracheal tube, reducing movement and friction that contribute to pressure injuries [^notfound].

---

## Limitations and considerations

While the trial results are promising, several limitations should be considered:

- **Sample size**: The trial included a relatively small sample size (105 patients), which may limit generalizability [^5f25870c].

- **Single-center design**: The trial was conducted in a single center, which may limit external validity.

- **Short-term follow-up**: The trial assessed outcomes over a short period, and long-term effects of the device remain unknown.

---

## Conclusion

The EIRPI trial demonstrated that the novel endotracheal tube fixation device **effectively prevented lip pressure injuries**, with no occurrences in the device group compared to 25.9% in the control group [^5cf4b597]. This significant reduction in lip pressure injuries highlights the device's potential to improve patient comfort, safety, and clinical outcomes in mechanically ventilated patients.

---

## References

### Effect of a self-developed fixation device on preventing endotracheal intubation-related pressure injury: a randomised controlled trial [^9f803379]. Critical Care (2024). Medium credibility.

Statistical analyses

We estimated the expected incidence of EIRPI to be 28% in the control group and 5% in the observation group based on the data from our preliminary test. The sample size was calculated using PASS software, version 15.0.5 (NCSS, LLC. Kaysville, Utah, USA) with 90% power and a two-sided alpha level of 0.05. Considering a 10% dropout rate, we planned to randomise 112 patients to achieve the 100 eligible patients required for our study.

All hypothesis tests were two-sided, and the threshold for significance was set to 0.05. The Shapiro–Wilk test was used to assess the normality of the distribution. Non-normally distributed continuous variables were presented as medians (quartile 1 and quartile 3), and the Mann–Whitney U-test was used to assess differences between the two groups. The proportions of categorical variables were compared using the Chi-squared test or Fisher's exact test, as appropriate. All analyses were performed using IBM SPSS Statistics for Windows, version 25.0.

---

### Effect of a self-developed fixation device on preventing endotracheal intubation-related pressure injury: a randomised controlled trial [^5cf4b597]. Critical Care (2024). Medium credibility.

Objective

To evaluate the effects of our self-developed endotracheal tube fixation device in mechanically ventilated patients.

Methods

In a dual-centre randomised controlled trial, patients who were expected to require mechanical ventilation for over 48 h were assigned to the observation group (using self-developed device) or the control group (using the traditional device). The primary endpoint was the incidence of endotracheal intubation-related pressure injury (EIRPI).

Results

Fifty-one patients in the observation group and 54 patients in the control group were analysed. The incidence of EIRPI was 7.8% in the observation group and 33.3% in the control group (p = 0.001). Lip pressure injury (PI) occurred in 0 versus 14 (25.9%) patients in the observation versus control groups (p < 0.001). Both oral–mucosal and facial PIs were similar between the two groups.

Conclusions

The use of the novel device reduced the incidence of EIRPI, especially lip PI.

Trial registration Chinese Clinical Trial Registry ChiCTR2300078132. Registered on 29 November 2023

---

### Effect of a self-developed fixation device on preventing endotracheal intubation-related pressure injury: a randomised controlled trial [^32872992]. Critical Care (2024). Medium credibility.

Methods

Study design

This prospective dual-centre randomised controlled trial aimed to compare the effect of a novel device (Fig. 1 A) versus a traditional device (Zhejiang Haisheng Medical Equipment Co. Ltd.) (Fig. 1 B) among critically ill adults requiring intubation and mechanical ventilation for at least 48 h. This study was approved by the Institutional Review Board of Nanjing Lishui People's Hospital and the Medical Ethics Committee of Xuzhou City Central Hospital.

Fig. 1
A Structure diagram of the self-developed endotracheal tube fixation device. B Structure diagram of the traditional endotracheal tube fixation device. C Photograph of the patient wearing the self-developed endotracheal tube fixation device. D Photograph of the patient wearing the traditional endotracheal tube fixation device

Study participants

Patients admitted to the intensive care unit (ICU) of the two hospitals from 14 November 2022 to 20 October 2023 who required endotracheal intubation and met the study's inclusion criteria were randomly allocated to two groups: the observation group with the novel device (Fig. 1 C) and the control group with the traditional device (Fig. 1 D).

The inclusion criteria were as follows: (1) age ≥ 18 years; (2) meeting the indications for endotracheal intubation; and (3) signing the informed consent by themselves or their family member.

The exclusion criteria were as follows: (1) patients who were not suitable for orotracheal intubation; (2) patients with damaged lip, facial skin, or oral mucosa before intubation; and (3) patients who were not suitable for wearing headbands.

Withdrawal criteria were as follows: (1) patients with intubation time/mechanical ventilation time < 48 h, (2) patients who abandoned the treatment during the trial, and (3) patients or family members who voluntarily requested withdrawal during the trial.

Randomisation

Patients were randomly allocated to the observation or control group by a person other than the researchers in a 1:1 ratio with random sequences generated using IBM SPSS Statistics for Windows, version 25.0 (IBM Corp. Armonk, NY, USA), stratified by centre. Allocation information was concealed using sealed opaque envelopes.

Study outcomes

The primary outcome was the appearance of any endotracheal intubation-related pressure injury (EIRPI) that occurred on the lips, oral mucosa, or facial skin during intubation. Secondary outcomes included duration of mechanical ventilation, tube dislodgement, and ventilator-associated pneumonia (VAP).

---

### Effect of a self-developed fixation device on preventing endotracheal intubation-related pressure injury: a randomised controlled trial [^374867f2]. Critical Care (2024). Medium credibility.

Conclusions

This study demonstrated that the novel device has therapeutic potential in preventing EIRPI, especially lip PI.

---

### Effect of a self-developed fixation device on preventing endotracheal intubation-related pressure injury: a randomised controlled trial [^aee423b6]. Critical Care (2024). Medium credibility.

Overall, the advantages of the novel device include shifting the point of force application away from the lips prone to EIRPI, minimising the risk of mechanical damage to the lips.

In our previous study, the novel device was used to successfully treat lip PI in a 79-year-old patient with diabetes.

This study has several limitations, including a dual-centre design, small sample size, limited research duration, and imprecise control of headband tension, and the control group is not a standard of care in every ICU. Moreover, the open-label study design with a subjective outcome, i.e. the number of PIs, could introduce bias into the findings. Future research should aim to improve methodology by integrating more objective assessment tools.

To improve understanding of the novel device used in mechanically ventilated patients, multi-centre studies are needed. Future research should investigate incorporating sensors into endotracheal tube fixation devices to monitor real-time data on skin conditions, blood perfusion, and tissue cell deformation, potentially reducing the incidence of EIRPI.

---

### Effect of a self-developed fixation device on preventing endotracheal intubation-related pressure injury: a randomised controlled trial [^31ca1602]. Critical Care (2024). Medium credibility.

Discussion

In this study, the observation group had a significantly lower incidence of EIRPI compared to the control group. The incidence of lip PI was significantly reduced, but there were no significant differences in oral–mucosal or facial PIs.

Recent studies have reported different rates of PIs with traditional endotracheal tube fixation devices. Sun et al. reported that the incidence of facial and lip PIs was 58.1%. Qin et al. reported that the incidence of EIRPI was 23.7% and that the lip was the most commonly affected area (76.7%). In our study, the incidence of EIRPI with a traditional device was 33.3%, which is comparable to the findings of the aforementioned two studies. We hypothesised that the variation in reported incidence may be due to differences in headband tension, as there were no devices to measure and tailor it for each patient.

The National Pressure Ulcer Advisory Panel recognises the vulnerability of mucosal tissue to PIs caused by medical devices such as endotracheal tube fixation devices, emphasising the potential for tissue ulcers due to applied pressure. In this study, the incidence of EIRPI was 8.7% in the observation group and 33.3% in the control group. The results confirmed that the novel device had significant advantages in preventing EIRPI, particularly lip PI.

We conclude the reasons for this to be:
Suitability of the contact area: The contact of the novel device with the skin of the face compared to the lips, it is less prone to mechanical damage. The facial skin has a higher degree of keratinisation, which provides stronger protective function.
Differences in the environment at the contact areas: The complex environment of the lips, including factors such as oral secretions and bacteria, increases the risk of PI. The moist environment of the lips weakens the mucosal barrier function and predisposes to secondary infection. On the other hand, the environment of the facial skin is simpler, and dressings placed at the skin–silicone interfaces can prevent the accumulation of skin moisture, reducing the occurrence of PI.
The use of silicone pads and dressings in the novel device promotes reduced and uniform pressure between the skin and device, thereby reducing the occurrence of PI.

---

### Effect of a self-developed fixation device on preventing endotracheal intubation-related pressure injury: a randomised controlled trial [^5f25870c]. Critical Care (2024). Medium credibility.

The study EIRPI was published by Xiaodong Zhang and colleagues in 2024 in the journal Crit Care. This study is related to the following diseases: Endotracheal intubation and Mechanical ventilation. In the EIRPI study, the trial question was: what is the role of self-developed endotracheal tube fixation device in patients undergoing mechanical ventilation? In the EIRPI study, the study design was: multi-center, open label, RCT. In the EIRPI study, the population was: 105 patients (35 female, 70 male). The inclusion criteria were patients who were expected to require mechanical ventilation for > 48 hours. The key exclusion criteria were unsuitable for orotracheal intubation; damaged lip, facial skin, or oral mucosa before intubation; unsuitable for wearing headbands. In the EIRPI study, the interventions were: n = 51 self-developed device (self-developed endotracheal tube fixation device) n = 54 traditional device (traditional endotracheal tube fixation device). In the EIRPI study, the primary outcome was: significant decrease in endotracheal intubation-related pressure injury (7.8% vs. 33.3%; ARD -25.5, 95% CI -40.63 to -10.37). In the EIRPI study, the secondary outcomes were: significant decrease in lip pressure injury (0% vs. 25.9%; ARD -25.9, 95% CI -41.27 to -10.53) No significant difference in ventilator-associated pneumonia (0% vs. 3.7%; ARD -3.7, 95% CI -14.21 to 6.81) No significant difference in oral mucosal pressure injury (3.9% vs. 9.3%; ARD 5.4, 95% CI -9.27 to 20.07). In the EIRPI study, the conclusion was: in patients who were expected to require mechanical ventilation for > 48 hours, self-developed device was superior to traditional device with respect to endotracheal intubation-related pressure injury.

---

### Prevention and treatment of pressure ulcers / injuries: quick reference guide prevention recommendations (fourth edition) [^a3f4d0c3]. NPIAP (2025). High credibility.

Device-related pressure injuries — clinical questions explore the impact on the number developing device-related pressure injury when alternating the type of device versus not alternating, repositioning the device versus not repositioning, using a pressure redistribution respiratory device versus a standard respiratory device, using a prophylactic dressing under a device versus no prophylactic dressing, and using a leave-on topical product under a device versus any no topical leave-on product in individuals at risk.

---

### Guidelines for the management of severe traumatic brain injury, fourth edition [^c92e8b72]. Neurosurgery (2017). Medium credibility.

Randomized controlled trial (RCT) comparison of ICP monitoring versus imaging/clinical assessment — Chesnut et al., 2012 — found no mortality difference and had high internal validity. Specifically, it "conducted a multi-center RCT in Bolivia and Ecuador that compared management guided by ICP monitoring to management guided by imaging and clinical assessment, and found no difference in 6-month mortality", with protocol fidelity and standardization, and "it was rated as Class 1". The trial "found reduced treatment time in the ICP monitor group and reduced incidence of pressure ulcers in the clinical assessment group". Although "the evidence from this study was not used to contribute to a recommendation in these guidelines (outcomes for treatment and control groups did not differ, therefore neither approach is recommended over the other), the study may contribute an empirically-based algorithm — based on its CT and clinical examination protocol — for the treatment of increased ICP in low technology settings". Other studies on this question "used observational study designs and were rated Class 2".

---

### Repositioning for preventing pressure injuries [^68a9caa0]. NPIAP (2025). High credibility.

Mobilization — Evidence for preventing pressure injuries indicates the meta-analysis included six RCTs and six non-randomized comparative studies and found a significantly lower rate of PI occurrence with early mobilization (5.2% versus 6.9%, RR 0.75, 95% CI 0.61 to 0.92, p = 0.009, relative effect of 17 fewer PIs per 1,000 individuals treated [from 27 fewer to 5 fewer]); however, there is very little confidence that this effect estimate represents a true effect and the evidence was downgraded due to a high risk of bias, indirectness and inconsistency.

---

### Alternating pressure (active) air surfaces for preventing pressure ulcers [^414bd00d]. The Cochrane Database of Systematic Reviews (2021). Medium credibility.

Assessment of risk of bias in included studies

Two review authors or researchers (CS and SR, AJB, EM, Zhenmi Liu, Gill Norman, or Melanie Stephens) independently assessed the risk of bias of each included study using the Cochrane 'Risk of bias' tool (see Appendix 3). This tool has seven specific domains: sequence generation (selection bias), allocation concealment (selection bias), blinding of participants and personnel (performance bias), blinding of outcome assessment (detection bias), incomplete data (attrition bias), selective outcome reporting (reporting bias), and other issues (Higgins 2017). We assessed performance bias, detection bias, and attrition bias for each of the review outcomes separately (Higgins 2017). We noted that it is often impossible to blind participants and personnel in device trials. In this case, performance bias may be introduced if knowledge of treatment allocation results in deviations from intended interventions, differential use of co‐interventions or care between groups not specified in the study protocol that may influence outcomes. We attempted to understand if, and how, included studies compensated for challenges in blinding; for example, implementing strict protocols to maximise consistency of co‐interventions between groups to reduce the risk of performance bias. We also noted that pressure ulcer incidence is a subjective outcome. Compared with blinded assessment, non‐blinded assessment of subjective outcomes tends to be associated with more optimistic effect estimates of experimental interventions in RCTs (Hróbjartsson 2012). Therefore, we judged non‐blinded outcome assessment as being at high risk of detection bias. In this review, we included the issues of differential diagnostic activity and unit of analysis under the domain of 'other issues'. For example, unit of analysis issues occurred where a cluster‐randomised trial had been undertaken but analysed at the individual level in the study report.

---

### Continuous pneumatic regulation of tracheal cuff pressure to decrease ventilator-associated pneumonia in trauma patients who were mechanically ventilated: the AGATE multicenter randomized controlled study [^5c00dae6]. Chest (2021). Medium credibility.

Background

Ventilator-associated pneumonia (VAP) is the most frequent health care-associated infection in severely ill patients, and aspiration of contaminated oropharyngeal content around the cuff of the tracheal tube is the main route of contamination.

Research Question

Is continuous regulation of tracheal cuff pressure using a pneumatic device superior to manual assessment three times daily using a portable manometer (routine care) in preventing VAP in patients with severe trauma?

Study Design and Methods

In this open-label, randomized controlled superiority trial conducted in 13 French ICUs, adults (age ≥ 18 years) with severe trauma (Injury Severity Score > 15) and requiring invasive mechanical ventilation for ≥ 48 h were enrolled. Patients were randomly assigned (1:1) via a secure Web-based random number generator in permuted blocks of variable sizes to one of two groups according to the method of tracheal cuff pressure control. The primary outcome was the proportion of patients developing VAP within 28 days following the tracheal intubation, as determined by two assessors masked to group assignment, in the modified intention-to-treat population. This study is closed to new participants.

Results

A total of 434 patients were recruited between July 31, 2015, and February 15, 2018, of whom 216 were assigned to the intervention group and 218 to the control group. Seventy-three patients (33.8%) developed at least one episode of VAP within 28 days following the tracheal intubation in the intervention group compared with 64 patients (29.4%) in the control group (adjusted subdistribution hazard ratio, 0.96; 95% CI, 0.76–1.20; P = 0.71). No serious adverse events related to the use of the pneumatic device were noted.

Interpretation

Continuous regulation of cuff pressure of the tracheal tube using a pneumatic device was not superior to routine care in preventing VAP in patients with severe trauma.

Clinical Trial Registration

ClinicalTrials.gov; No.: NCT02534974; URL: www.clinicaltrials.gov.

---

### Pressure relieving support surfaces for pressure ulcer prevention (PRESSURE 2): clinical and health economic results of a randomised controlled trial [^7b203bfc]. EClinicalMedicine (2019). Medium credibility.

The findings provide the RCT evidence to underpin current guidelines which recommend the use of HSF for patients at risk of PU and consideration of 'high tech' mattresses where HSF is failing. This study will inform recommendation revisions and the grade of evidence on which recommendations are based. Current device regulations fall short in the requirement for evidence of clinical effectiveness and can result in widespread adoption of 'high tech' solutions prior to demonstrated clinical or patient benefit.

---

### Pressure relieving support surfaces for pressure ulcer prevention (PRESSURE 2): clinical and health economic results of a randomised controlled trial [^9459e182]. EClinicalMedicine (2019). Medium credibility.

Table 7
Time to development of new PU Category ≥ 2 by 30 day final follow-up.

Fig. 2
a-d: Survival analysis (Cumulative incidence functions for time to development of PUs).

In the treatment phase sensitivity analysis, 132 (6.5%) developed new PU Category ≥ 2 between randomisation and end of treatment phase (APM 53(5.2%), HSF 79 (7.8%)) with a statistically significant difference observed in time to development of PU Category ≥ 2 in the Fine and Gray model (HR = 0.66(95% CI, 0.46 to 0.93; exact P = 0.0176)) (see eDocument 8a).

350 (17.2%) patients reached the secondary endpoint of developing a new PU Category ≥ 1 by 30 day final follow-up (APM 160(15.7%), HSF 190(18.8%)), with no evidence of a difference in the time to event (Fine and Gray model (HR = 0.83(95% CI, 0.67 to 1.02; exact P = 0.0733))) (see eDocument 8b).

32 (1.6%) patients reached the secondary endpoint of developing a new PU Category ≥ 3 by 30 day final follow-up (APM 14(1.4%), HSF 18(1.8%)) with no evidence of a difference in the time to event (Fine and Gray model (HR = 0.81(95% CI, 0.40 to 1.62; exact P = 0.5530)) (see eDocument 8c)). The number of Category ≥ 3 PUs were comparable by arm (APM N = 19 vs HSF N = 21).

Of 145 patients with a pre-existing PU Category 2 (APM 70(48.3%), HSF 75(51.7%)), healing was observed in 89 (APM 44(62.9%); HSF 45(60.0%)) (see eDocument 8d), with no evidence of a difference in the time to event (Fine and Gray model (HR = 1.12 (95% CI, 0.74 to 1.68; exact P = 0.6122))).

---

### A randomized clinical trial of wheeled mobility for pressure injury prevention and better function [^b27dc9db]. Journal of the American Geriatrics Society (2018). Low credibility.

Objectives

To evaluate the effectiveness of wheelchair assessment and configuration on pressure injury incidence, mobility, and functioning in a wheelchair.

Design

Randomized controlled trial with participants individually randomized into intervention and control groups.

Setting

Nursing home.

Participants

Nursing home residents aged 60 and older who used wheelchairs and were at risk for pressure injuries (N = 258).

Intervention

Treatment and evaluation, individually configured wheelchair and skin protection cushion; control and evaluation, facility-provided wheelchair and skin protection cushion.

Measurements

Pressure injury incidence, Nursing Home Life Space Diameter score, Functioning Every Day in a Wheelchair-Capacity (FEW-C) score, and Wheelchair Skills Test (WST) score.

Results

No differences in pressure injuries (p = .77) were found. Pelvic rotation (odds ratio (OR) = 0.15, 95% confidence interval (CI) = 0.03–0.70, p = .02) and Day 14 WST skill score (OR = 0.74, 95% CI = 0.60–0.91, p = .004) were significant predictors of pressure injuries. Significant differences were observed between groups in change in FEW-C independence scores between before randomization and endpoint (p = .03) and before randomization and 14 days (p = .04).

Conclusion

Participants with individually configured wheelchairs improved more in the safe and effective use of their wheelchairs than residents with facility-provided wheelchairs. The outcomes indicated that nursing home residents functioned safely at a higher level in their wheelchairs if their devices were individually configured using a comprehensive wheelchair and seating assessment process. There was no difference in the incidence of pressure injuries between the two groups.

Trial Registration

NCT01275313.

---

### Silicone adhesive multilayer foam dressings as adjuvant prophylactic therapy to prevent hospital-acquired pressure ulcers: a pragmatic noncommercial multicentre randomized open-label parallel-group medical device trial [^9302a955]. The British Journal of Dermatology (2021). Medium credibility.

Summary

Background

Silicone adhesive multilayer foam dressings are used as adjuvant therapy to prevent hospital‐acquired pressure ulcers (PUs).

Objectives

To determine whether silicone foam dressings in addition to standard prevention reduce the incidence of PUs of category 2 or worse compared with standard prevention alone.

Methods

This was a multicentre, randomized controlled medical device trial conducted in eight Belgian hospitals. At‐risk adult patients were centrally randomized (n = 1633) to study groups based on a 1: 1: 1 allocation: experimental groups 1 (n = 542) and 2 (n = 545) – pooled as the treatment group – and the control group (n = 546). The experimental groups received PU prevention according to hospital protocol, and a silicone foam dressing on the relevant body sites. The control group received standard of care. The primary endpoint was the incidence of a new PU of category 2 or worse at the studied body sites.

Results

In the intention‐to‐treat population (n = 1605), PUs of category 2 or worse occurred in 4·0% of patients in the treatment group and 6·3% in the control group [relative risk (RR) 0·64, 95% confidence interval (CI) 0·41–0·99, P = 0·04]. Sacral PUs were observed in 2·8% and 4·8% of the patients in the treatment group and the control group, respectively (RR 0·59, 95% CI 0·35–0·98, P = 0·04). Heel PUs occurred in 1·4% and 1·9% of patients in the treatment and control groups, respectively (RR 0·76, 95% CI 0·34–1·68, P = 0·49).

Conclusions

Silicone foam dressings reduce the incidence of PUs of category 2 or worse in hospitalized at‐risk patients when used in addition to standard of care. The results show a decrease for the sacrum, but no statistical difference for the heel and trochanter areas.

---

### Silicone adhesive multilayer foam dressings as adjuvant prophylactic therapy to prevent hospital-acquired pressure ulcers: a pragmatic noncommercial multicentre randomized open-label parallel-group medical device trial [^abf684ea]. The British Journal of Dermatology (2021). Medium credibility.

Table 3
Incidence of pressure ulcers of category 2 or worse, by intervention group stratified by patient characteristics (intention‐to‐treat analyses)

A sensitivity analysis was conducted (ITT population) based on centrally confirmed PUs by blinded review of photographs by the chief investigator. Among the 77 new PUs of category 2 or worse reported by local assessment in the ITT population (n = 1065), 68 had photographs of sufficient quality and were assessed. Of these, 56 (82%) were confirmed as a PU of category 2 or worse by central review. All PP analyses confirmed the ITT analyses, as described in the clinical study report.

No serious ADEs were reported in the safety population (n = 1077) during the study. Thirty‐three ADEs were reported in 28 patients. Most of them were mechanical skin injuries (skin tears or skin stripping, n = 11), PU formation (two of PU category 1, one of PU category 2) and blister formation at the edge of or underneath the dressing (n = 3). These injuries were anecdotally attributed to the dressing being 'rolled up', having 'rolled edges' or being 'wrinkled up', alluding to the inability of some of the dressings to stay in place, causing tension injuries on the skin. Heel dressings caused two patient falls, without significant harm, when the dressing was in direct contact with the floor (Table 4).

Table 4
Number of adverse device effects and device deficiencies, safety population

From the DD group in the safety population, 246 DDs were reported in 97 patients. Some of the seven categories identified related to the subsequent ADEs reported, namely poor adhesion or adhesion failure (n = 127), rolled‐up edges (n = 44) and dressing causing the floor to be slippery for others (n = 26); in one case of the latter this resulted in a fall, without significant harm. Other DDs noted were dressing layer separation, adhesive residue on the skin, adhesive transfer or poor release of the backing film or liner from the dressing, and footwear obstruction (Table 4).

---

### Repositioning for pressure injury prevention in adults [^8f6b46b5]. The Cochrane Database of Systematic Reviews (2020). Medium credibility.

Background

A pressure injury (PI), also referred to as a 'pressure ulcer', or 'bedsore', is an area of localised tissue damage caused by unrelieved pressure, friction, or shearing on any part of the body. Immobility is a major risk factor and manual repositioning a common prevention strategy. This is an update of a review first published in 2014.

Objectives

To assess the clinical and cost effectiveness of repositioning regimens(i.e. repositioning schedules and patient positions) on the prevention of PI in adults regardless of risk in any setting.

Search Methods

We searched the Cochrane Wounds Specialised Register, the Cochrane Central Register of Controlled Trials (CENTRAL), Ovid MEDLINE, Ovid Embase, and EBSCO CINAHL Plus on 12 February 2019. We also searched clinical trials registries for ongoing and unpublished studies, and scanned the reference lists of included studies as well as reviews, meta-analyses, and health technology reports to identify additional studies. There were no restrictions with respect to language, date of publication, or study setting.

Selection Criteria

Randomised controlled trials (RCTs), including cluster-randomised trials (c-RCTs), published or unpublished, that assessed the effects of any repositioning schedule or different patient positions and measured PI incidence in adults in any setting.

Data Collection and Analysis

Three review authors independently performed study selection, 'Risk of bias' assessment, and data extraction. We assessed the certainty of the evidence using GRADE.

Main Results

We identified five additional trials and one economic substudy in this update, resulting in the inclusion of a total of eight trials involving 3941 participants from acute and long-term care settings and two economic substudies in the review. Six studies reported the proportion of participants developing PI of any stage. Two of the eight trials reported within-trial cost evaluations. Follow-up periods were short (24 hours to 21 days). All studies were at high risk of bias. Funding sources were reported in five trials. Primary outcomes: proportion of new PI of any stage Repositioning frequencies: three trials compared different repositioning frequencies We pooled data from three trials (1074 participants) comparing 2-hourly with 4-hourly repositioning frequencies (fixed-effect; I² = 45%; pooled risk ratio (RR) 1.06, 95% confidence interval (CI) 0.80 to 1.41). It is uncertain whether 2-hourly repositioning compared with 4-hourly repositioning used in conjunction with any support surface increases or decreases the incidence of PI. The certainty of the evidence is very low due to high risk of bias, downgraded twice for risk of bias, and once for imprecision. One of these trials had three arms (967 participants) comparing 2-hourly, 3-hourly, and 4-hourly repositioning regimens on high-density mattresses; data for one comparison was included in the pooled analysis. Another comparison was based on 2-hourly versus 3-hourly repositioning. The RR for PI incidence was 4.06 (95% CI 0.87 to 18.98). The third study comparison was based on 3-hourly versus 4-hourly repositioning (RR 0.20, 95% CI 0.04 to 0.92). The certainty of the evidence is low due to risk of bias and imprecision. In one c-RCT, 262 participants in 32 ward clusters were randomised between 2-hourly and 3-hourly repositioning on standard mattresses and 4-hourly and 6-hourly repositioning on viscoelastic mattresses. The RR for PI with 2-hourly repositioning compared with 3-hourly repositioning on standard mattress is imprecise (RR 0.90, 95% CI 0.69 to 1.16; very low-certainty evidence). The CI for PI include both a large reduction and no difference for the comparison of 4-hourly and 6-hourly repositioning on viscoelastic foam (RR 0.73, 95% CI 0.53 to 1.02). The certainty of the evidence is very low, downgraded twice due to high risk of bias, and once for imprecision. Positioning regimens: four trials compared different tilt positions We pooled data from two trials (252 participants) that compared a 30° tilt with a 90° tilt (random-effects; I² = 69%). There was no clear difference in the incidence of stage 1 or 2 PI. The effect of tilt is uncertain because the certainty of evidence is very low (pooled RR 0.62, 95% CI 0.10 to 3.97), downgraded due to serious design limitations and very serious imprecision. One trial involving 120 participants compared 30° tilt and 45° tilt with 'usual care' and reported no occurrence of PI events (low certainty evidence). Another trial involving 116 ICU patients compared prone with the usual supine positioning for PI. Reporting was incomplete and this is low certainty evidence. Secondary outcomes No studies reported health-related quality of life utility scores, procedural pain, or patient satisfaction. Cost analysis Two included trials also performed economic analyses. A cost-minimisation analysis compared the costs of 3-hourly and 4-hourly repositioning with 2-hourly repositioning schedule amongst nursing home residents. The cost of repositioning was estimated at CAD 11.05 and CAD 16.74 less per resident per day for the 3-hourly or 4-hourly regimen, respectively, compared with the 2-hourly regimen. The estimates of economic benefit were driven mostly by the value of freed nursing time. The analysis assumed that 2-, 3-, or 4-hourly repositioning is associated with a similar incidence of PI, as no difference in incidence was observed. A second study compared the nursing time cost of 3-hourly repositioning using a 30° tilt with standard care (6-hourly repositioning with a 90° lateral rotation) amongst nursing home residents. The intervention was reported to be cost-saving compared with standard care (nursing time cost per patient EUR 206.60 versus EUR 253.10, incremental difference EUR -46.50, 95% CI EUR -1.25 to EUR -74.60).

Authors' Conclusions

Despite the addition of five trials, the results of this update are consistent with our earlier review, with the evidence judged to be of low or very low certainty. There remains a lack of robust evaluations of repositioning frequency and positioning for PI prevention and uncertainty about their effectiveness. Since all comparisons were underpowered, there is a high level of uncertainty in the evidence base. Given the limited data from economic evaluations, it remains unclear whether repositioning every three hours using the 30° tilt versus "usual care" (90° tilt) or repositioning 3-to-4-hourly versus 2-hourly is less costly relative to nursing time.

---

### Foam surfaces for preventing pressure ulcers [^a715e182]. The Cochrane Database of Systematic Reviews (2021). Medium credibility.

Assessment of risk of bias in included studies

Two review authors or researchers (CS and SR, EM, Zhenmi Liu, Gill Norman, or Melanie Stephens) independently assessed risk of bias of each included study using the Cochrane 'Risk of bias' tool (see Appendix 3). This tool has seven specific domains: random sequence generation (selection bias), allocation concealment (selection bias), blinding of participants and personnel (performance bias), blinding of outcome assessment (detection bias), incomplete data (attrition bias), selective outcome reporting (reporting bias), and other issues (Higgins 2017). We assessed performance bias, detection bias, and attrition bias separately for each of the review outcomes (Higgins 2017). We noted that it is often impossible to blind participants and personnel in device trials. In this case, performance bias may be introduced if knowledge of treatment allocation results in deviations from intended interventions, differential use of co‐interventions or care between groups not specified in the study protocol that may influence outcomes. We attempted to understand if, and how, included studies compensated for challenges in blinding; for example, implementing strict protocols to maximise consistency of co‐interventions between groups to reduce the risk of performance bias. We also noted that pressure ulcer incidence is a subjective outcome. Compared with blinded assessment, non‐blinded assessment of subjective outcomes tends to be associated with more optimistic effect estimates of experimental interventions in RCTs (Hróbjartsson 2012). Therefore, we judged non‐blinded outcome assessment as being at high risk of detection bias. In this review, we included the issues of differential diagnostic activity and unit of analysis under the domain of 'other issues'. For example, unit of analysis issues occurred where a cluster‐randomised trial had been undertaken but analysed at the individual level in the study report.

---

### Prevention and treatment of pressure ulcers / injuries: quick reference guide prevention recommendations (fourth edition) [^d1dc290c]. NPIAP (2025). High credibility.

Pressure injuries — prophylactic dressings clinical questions assess the impact of any prophylactic dressing on the number of individuals who develop a new pressure injury compared to no product, compared to any other prophylactic dressing, and compared to a leave-on topical product, in individuals at risk of pressure injuries.

---

### Pressure injuries: prevention, evaluation, and management… [^aa48ddfc]. AAFP (2023). Medium credibility.

Evaluation Staging of a pressure injury should use the updated National Pressure Injury Advisory Panel staging system. Risk Assessment Assessing for risk factors is crucial to ensure appropriate prevention and plan of care. National Institute for Health and Care Excellence guidelines and those developed jointly by the European Pressure Ulcer Advisory Panel, NPIAP, and Pan Pacific Pressure Injury Alliance recommend a comprehensive clinical assessment for any risk factors central to the pathophysiology of pressure injury development, such as sensory loss, malnutrition, inactivity, immobility, and reduced perfusion. 1, 10 The risk assessment should focus on factors that influence the magnitude, type, and duration of pressure, as well as patient-specific factors that impact individual tolerance and susceptibility to injury 1, 11.

Reduced activity and mobility increase mechanical load and are consistently associated with the development of pressure injuries. 1, 12. Particular attention should be placed on populations at higher risk of pressure injuries, including people who are critically ill; individuals with spinal cord injuries or other immobility conditions; people receiving palliative care; acutely ill and immobilized neonates and children; people with obesity; people in the preoperative period; and people in the community receiving care for advanced age or requiring facility rehabilitation services due to mobility limitations. 18, 19 Although many algorithms have been validated, their sensitivity and specificity for identifying patients at risk of pressure injuries are low. 4, 17 Despite the prevalent use of risk assessment tools, there is no evidence of reduced pressure injuries associated with any scale.

4, 20 EPUAP/NPIAP/PPPIA guidelines and Agency for Healthcare Research and Quality best practices recommend an initial assessment on hospital admission, with reassessments depending on illness acuity and the specific care setting, although a paucity of evidence limits specific recommendations. 1, 21. 1, 41 However, a Cochrane review notes that data are insufficient to recommend widespread use outside of research. 46 Ultrasound can be used for Stage 3 or 4 pressure injuries to supplement other treatments. 1 Negative pressure wound therapy using vacuum-assisted closure can be used adjunctively for early Stage 3 or 4 injuries to reduce the size of wounds, particularly in patients with spinal cord injuries.

---

### Pressure ulcers: effectiveness of risk-assessment tools. A randomised controlled trial (the ULCER trial) [^e86243b3]. BMJ Quality & Safety (2011). Medium credibility.

Objective

To evaluate the effectiveness of two pressure-ulcer screening tools against clinical judgement in preventing pressure ulcers.

Design

A single blind randomised controlled trial.

Setting

A large metropolitan tertiary hospital.

Participants

1231 patients admitted to internal medicine or oncology wards. Patients were excluded if their hospital stay was expected to be 2 days or less.

Interventions

Participants allocated to either a Waterlow (n = 410) or Ramstadius (n = 411) screening tool group or to a clinical judgement group (n = 410) where no formal risk screening instrument was used.

Main Outcome Measure

Incidence of hospital acquired pressure ulcers ascertained by regular direct observation. Use of any devices for the prevention of pressure ulcers, documentation of a pressure plan and any dietetic or specialist skin integrity review were recorded.

Results

On admission, 71 (5.8%) patients had an existing pressure ulcer. The incidence of hospital-acquired pressure ulcers was similar between groups (clinical judgement 28/410 (6.8%); Waterlow 31/411 (7.5%); Ramstadius 22/410 (5.4%), p = 0.44). Significant associations with pressure injury in regression modelling included requiring a dietetic referral, being admitted from a location other than home and age over 65 years.

Conclusion

The authors found no evidence to show that two common pressure-ulcer risk-assessment tools are superior to clinical judgement to prevent pressure injury. Resources associated with use of these tools might be better spent on careful daily skin inspection and improving management targetted at specific risks.

Study Registration

The trial was registered with the Australian and New Zealand Clinicat Trials Registry (ACTRN 12608000541303).

---

### A trial of intracranial-pressure monitoring in traumatic brain injury [^e2ea1b7b]. The New England Journal of Medicine (2012). Excellent credibility.

Background

Intracranial-pressure monitoring is considered the standard of care for severe traumatic brain injury and is used frequently, but the efficacy of treatment based on monitoring in improving the outcome has not been rigorously assessed.

Methods

We conducted a multicenter, controlled trial in which 324 patients 13 years of age or older who had severe traumatic brain injury and were being treated in intensive care units (ICUs) in Bolivia or Ecuador were randomly assigned to one of two specific protocols: guidelines-based management in which a protocol for monitoring intraparenchymal intracranial pressure was used (pressure-monitoring group) or a protocol in which treatment was based on imaging and clinical examination (imaging-clinical examination group). The primary outcome was a composite of survival time, impaired consciousness, and functional status at 3 months and 6 months and neuropsychological status at 6 months; neuropsychological status was assessed by an examiner who was unaware of protocol assignment. This composite measure was based on performance across 21 measures of functional and cognitive status and calculated as a percentile (with 0 indicating the worst performance, and 100 the best performance).

Results

There was no significant between-group difference in the primary outcome, a composite measure based on percentile performance across 21 measures of functional and cognitive status (score, 56 in the pressure-monitoring group vs. 53 in the imaging-clinical examination group; P = 0.49). Six-month mortality was 39% in the pressure-monitoring group and 41% in the imaging-clinical examination group (P = 0.60). The median length of stay in the ICU was similar in the two groups (12 days in the pressure-monitoring group and 9 days in the imaging-clinical examination group; P = 0.25), although the number of days of brain-specific treatments (e.g., administration of hyperosmolar fluids and the use of hyperventilation) in the ICU was higher in the imaging-clinical examination group than in the pressure-monitoring group (4.8 vs. 3.4, P = 0.002). The distribution of serious adverse events was similar in the two groups.

Conclusions

For patients with severe traumatic brain injury, care focused on maintaining monitored intracranial pressure at 20 mm Hg or less was not shown to be superior to care based on imaging and clinical examination. (Funded by the National Institutes of Health and others; ClinicalTrials.gov number, NCT01068522.).

---

### Repositioning for preventing pressure injuries [^5e89c2ec]. NPIAP (2025). High credibility.

Repositioning for preventing pressure injuries — perioperative guidance includes the following: "Evaluate individuals who enter the perioperative setting with medical devices in situ to determine how positioning and instrumentation may impact their pressure injury risk. Do not position the individual directly on a medical device unless it cannot be avoided". "Plan to reposition the individual during surgery where possible, especially for longer procedures (i.e. longer than 2 hours)". "Repositioning can be determined by the type of surgery, the surgical position, the duration of the surgery and the individual's clinical condition". "IP mapping is another option to identify the need to reposition". "At commencement of the surgery, determine when during the procedure the individual could be repositioned so the team is prepared to take a short procedural break". "This may be done using small shifts of body weight (micromovements) and/or repositioning the extremities if the surgery is of longer duration". "Document the position in which the individual was placed during surgery, including any straps or securements".

---

### Silicone adhesive multilayer foam dressings as adjuvant prophylactic therapy to prevent hospital-acquired pressure ulcers: a pragmatic noncommercial multicentre randomized open-label parallel-group medical device trial [^356afaf0]. The British Journal of Dermatology (2021). Medium credibility.

As the trial results showed no clear effect on the heels, a risk–benefit analysis should be considered when applying prophylactic dressings on the heels to determine whether any potential benefits of protecting the heels outweigh the reported risk of falls. The product specifications highlight differences in construction and adhesive properties between the two study dressings. This may explain the differences in the ADEs and DDs (Table 4). No known standards exist for this product class despite their widespread and growing use. This conclusion feeds the discussion about the need for performance standards for prophylactic dressings. In November 2020, the European Pressure Ulcer Advisory Panel and the National Pressure Injury Advisory Panel announced the establishment of an international task force to develop such performance standards. These standards will generate critical information to guide (i) effective clinical product selection and practice, (ii) benchmarks for development purposes and (iii) reimbursement policies.

It should be reiterated that the use of silicone adhesive multilayer foam dressings might be an additional intervention to obtain adequate PU prevention, and that the current standard guidelines for PU prevention still remain the cornerstone of prevention. The risk exists that applying a prophylactic dressing on an at‐risk patient will create a false sense of security for the clinician, leading to the remaining 'standard of care' of PU prevention being ignored; however, there was no suggestion of this happening in this study. If prophylactic dressings are added to PU prevention strategies, the protocols should stress the importance of education, daily skin assessment underneath the dressing, and monitoring of the adherence to the protocol.

There were some limitations to this study. Performance and detection bias may have occurred because patients, caregivers and study personnel could not be blinded to the study procedures and devices. However, the results were consistent when based on confirmed PUs by review of photographs, all study nurses were trained, and for most hospitals their wound care teams were involved when a PU occurred, further strengthening the correct identification of skin injuries. As the organization of care and staff characteristics is setting specific, generalizability to other hospitals in other regions might be limited. However, there was a range of hospital types (university and general hospitals), the hospital standard prevention protocols corresponded to the international state‐of‐the‐art recommendations, and the treatment effect is consistent with the results of previous RCTs.

---

### Effectiveness and safety of prolonged prone positioning in adult patients with acute respiratory distress syndrome (ARDS): a systematic review and meta-analysis [^dba14cba]. Critical Care (2025). Medium credibility.

Adverse events

Overall, seven studies reported the incidence of pressure injuries. In the crude analysis including all results, no significant difference was observed between groups (RR 1.46; 95% CI 0.94 to 2.27; I² = 47.1%; n = 664; Fig. 6 A). When restricted to studies with low to moderate risk of bias, two RCTs studies (n = 112) were available. None of the NRSIs reported adjusted data for this endpoint. Meta‑analysis again revealed no significant difference between groups (RR 1.79; 95% CI 0.00–284,136.72; I² = 85.4%; Fig. 6 B), although heterogeneity was substantial, largely reflecting variability in the frequency of reported injuries. The trial by Sáez de la Fuente et al. showed the highest risk in the prolonged‑prone group, corresponding with both the longest cumulative prone duration and the largest difference between intervention and control groups (Fig. 4).

Fig. 6
Comparison of the incidence of pressure injuries between prolonged and standard prone position groups. A = Synthesis including all studies reporting the incidence of pressure injuries. B = Synthesis restricted to studies with low to moderate risk of bias

Four studies (three RCTs and one NRSI; 427 patients) reported the incidence of catheter or endotracheal tube dislodgement. These events were rare across all studies, with no heterogeneity detected (I² = 0%). Meta‑analysis demonstrated no significant difference between prolonged and standard pronation (RR 0.86; 95% CI 0.18–4.13; Fig. 7).

Fig. 7
Comparison of the incidence of loss-of-catheters or endotracheal tubes between prolonged and standard prone position groups. Synthesis includes all studies reporting the incidence of loss-of-catheters or endotracheal tubes

Sensitivity analyses

Sensitivity analyses including (a) separate analyses of RCT and NRSI data and (b) mortality analysis at the latest available timepoint, including each study's maximum reported follow-up (e.g. 30-day, 90-day, or ICU mortality), did not reveal any trends or statistically significant associations beyond those observed in the main analyses (Figures S1–S2).

---

### Pressure relieving support surfaces for pressure ulcer prevention (PRESSURE 2): clinical and health economic results of a randomised controlled trial [^3f2c79c1]. EClinicalMedicine (2019). Medium credibility.

Risk factors found to be predictive of PU development in the adjusted analysis (Tables 8a–8c in eDocument 8: Additional results tables) are in line with previous work and adds to the growing body of evidence that a key risk factor in immobile patients is skin status including presence of Category 1 and Category 2 PU.

No safety concerns were indicated for either APMs or HSF. Concerns expressed in previous research by patients about feeling unsafe on APMswere not reflected in falls which were balanced across groups and consistent with those reported in acutely ill hospital populationsand community dwelling settings.

The trial recruited more slowly than originally anticipated leading to a smaller sample size than the planned maximum sample size (2029 compared to 2954 patients), with fewer events (160 compared to 588) and was therefore underpowered under the original trial design assumptions. Under the revised design, the trial had 80% power for detecting a difference of 4% between mattress groups assuming an overall event rate of 10% with corresponding hazard ratio of 0.652. The overall event rate observed was lower at 7.9% with an absolute difference of 2.0% between mattress groups, and corresponding hazard ratio of 0.76. The a priori discussions with the TMG on the revised minimum clinically important difference for varying overall event rates (3.3% difference for 10% event rate, 2.5% difference for 5% event rate — see Methods and eDocument 5) suggest that the difference observed may not be considered to be clinically important. If APMs were allocated to patients fulfilling the trial inclusion criteria, the difference equates to a Number Needed to Treat (NNT) of 50. That means that for every 50 patients allocated an APM it will benefit only 1 patient.

---

### Prevention and treatment of pressure ulcers / injuries: quick reference guide prevention recommendations (fourth edition) [^03665365]. NPIAP (2025). High credibility.

Pressure injuries — skin and tissue assessment under development includes Good Practice Statements for conducting visual and tactile assessment across the continuum of skin tones and clinical questions on the impact of technology-assisted skin and tissue assessment for detection of pressure injuries, including Deep Tissue Pressure Injury not detectable with visual and tactile assessment, for identifying early tissue injury, and for prevention strategies designed to address areas of early injury on pressure injury occurrence in individuals at risk.

---

### 2024 American Heart Association and American red cross guidelines for first aid [^6ebfd78a]. Circulation (2024). High credibility.

External bleeding control — supportive evidence for direct manual pressure: In 3 different RCTs conducted in hospitalized participants undergoing endovascular procedures, there was a shorter time to bleeding cessation for bleeding arterial wounds with the use of direct manual pressure than with the use of at least some mechanical compression devices.

---

### Pressure relieving support surfaces for pressure ulcer prevention (PRESSURE 2): clinical and health economic results of a randomised controlled trial [^6b602ad1]. EClinicalMedicine (2019). Medium credibility.

2.7 Role of Funding Source

This project was funded by the(NIHR) Health Technology Assessment (HTA) programme (project number 11/36/33). The funder monitored recruitment, requested an unplanned interim and VOI analysis, reviewed the VOI analysis and the recommendations of the TSC and DMC for trial continuation and made the final decision for an unfunded time extension to meet the revised minimum of 1996 participants.

---

### Repositioning for preventing pressure injuries [^41d681c5]. NPIAP (2025). High credibility.

Repositioning — additional considerations for individuals who can self‑reposition advise to provide individuals with assistive devices to promote bed mobility and self‑repositioning and ensure these devices are readily accessible.

---

### Effect of a continuous bedside pressure mapping system for reducing interface pressures: a randomized clinical trial [^6f6cfab0]. JAMA Network Open (2023). High credibility.

Importance

Continuous bedside pressure mapping (CBPM) technology can assist in detecting skin areas with excessive interface pressure and inform efficient patient repositioning to prevent the development of pressure injuries (PI).

Objective

To evaluate the efficacy of CBPM technology in reducing interface pressure and the incidence of PIs.

Design, Setting, and Participants

This parallel, 2-group randomized clinical trial was performed at a tertiary acute care center. The study started to enroll participants in December 2014 and was completed in May 2018. Participants included adults partially or completely dependent for bed mobility. Statistical analysis was performed from September 2018 to December 2022.

Intervention

Nursing staff using visual feedback from CBPM technology for 72 hours.

Main Outcomes and Measures

Absolute number of sensing points with pressure readings greater than 40 mm Hg, mean interface pressure across all sensing points under a patient's body, proportion of participants who had pressure readings greater than 40 mm Hg, and pressure-related skin and soft tissue changes.

Results

There were 678 patients recruited. After attrition, 260 allocated to the control group (151 [58.1%] male; mean [SD] age, 61.9 [18.5] years) and 247 in the intervention group (147 [59.5%] male; mean [SD] age, 63.6 [18.1] years) were included in analyses. The absolute number of sensing points with pressures greater than 40 mm Hg were 11 033 in the control group vs 9314 in the intervention group (P = 0.16). The mean (SD) interface pressure was 6.80 (1.63) mm Hg in the control group vs 6.62 (1.51) mm Hg in the intervention group (P = 0.18). The proportion of participants who had pressure readings greater than 40 mm Hg was 99.6% in both the control and intervention groups.

Conclusions and Relevance

In this randomized clinical trial to evaluate the efficacy of CBPM technology in the reduction of interface pressure and the incidence of PIs in a tertiary acute care center, no statistically significant benefit was seen for any of the primary outcomes. These results suggest that longer duration of monitoring and adequately powered studies where CBPM feedback is integrated into a multifaceted intervention to prevent PI are needed.

Trial Registration

ClinicalTrials.gov Identifier: NCT02325388.

---

### Prevention and treatment of pressure ulcers / injuries: quick reference guide prevention recommendations (fourth edition) [^1f4ba64b]. NPIAP (2025). High credibility.

Repositioning for preventing pressure injuries — repositioning interval recommendation specifies: We suggest not routinely extending repositioning intervals to four, five or six hourly for individuals at risk of pressure injuries, categorized as a Conditional recommendation with Very low certainty of evidence based on Tiers 1, 2, 3A evidence.

---

### Pressure control plus spontaneous ventilation versus volume assist-control ventilation in acute respiratory distress syndrome. A randomised clinical trial [^1ef4e345]. Intensive Care Medicine (2024). Medium credibility.

Discussion

The present randomised clinical trial enrolling a large number of ARDS patients showed that the systematic use of a specific pressure-controlled mode of ventilation (namely PC-SV) which tends to favour spontaneous ventilation while minimising its risks, did not impact mortality and the number of ventilator and organ failure-free days, but reduced the need for sedation compared to the conventional ACV strategy.

During the first week of treatment, incidence of refractory hypoxemia did not differ, but a lower proportion of patients required adjunctive treatments of hypoxemia in the PC-SV group than in the ACV group. In particular, prone position was less frequently used in the PC-SV than in the ACV group. The incidence of pneumothorax during the first 28 days was similar in both groups.

PC-SV strategy

Pressure controlled ventilation is an alternative to ACV, whose physiological effects have been well described. PC-SV mode used in the study has some similarities with the mode usually referred as APRV, which permits to deliver two positive-pressure levels, allowing unrestricted and unsupported spontaneous breathing during any phase of the respiratory cycle (i.e. at the two pressure levels). PC-SV uses the same working principles as APRV (two pressure levels, no synchronisation) but is adjusted with conventional insufflation time and respiratory rate (contrary to classical APRV set with very short expiratory time). The difference with classical pressure-assist control is that patients' efforts cannot trigger assisted breaths. We hypothesised that PC-SV could help to maintain a lung protective ventilation and benefit from the expected effects of non-synchronised non-assisted spontaneous breathing. Synchronisation may indeed favour large volumes and distending pressures by adding patient' effort on top of mandatory insufflation or generate breath-stacking that may be injurious for the lungs.

The combination of the PC-SV settings with a dedicated protocol to obtain a SV amounting 10–50% of total minute ventilation, was defined based on a bench and clinical study suggesting its feasibility and safety.

The objectives of spontaneous ventilation were defined based on this study showing a maintenance of tidal volume around 6 mL/kg PBW even when spontaneous ventilation reached around 50% of total minute ventilation. In this context, the present study is the first one to assess in a large series of ARDS patients the potential benefit on patients' outcomes of spontaneous ventilation favoured by a specific mode of ventilation, all other settings being equal.

---

### Prevention and treatment of pressure ulcers / injuries: quick reference guide prevention recommendations (fourth edition) [^d7031b99]. NPIAP (2025). High credibility.

Preventing heel pressure injuries — pillows or cushions when devices are unavailable or inappropriate (H3) states: It is good practice to elevate the heels of individuals at risk of pressure injuries using standard pillows or cushions with sufficient height to ensure the heels are not in contact with the support surface, if a heel offloading device is not available or is inappropriate for the individual's activity and mobility level, with certainty Supported by indirect evidence & clinical expertise.

---

### Prevention and treatment of pressure ulcers / injuries: quick reference guide prevention recommendations (fourth edition) [^7520a553]. NPIAP (2025). High credibility.

Preventing heel pressure injuries — heel offloading device (H2) provides a conditional recommendation: We suggest using a heel offloading device that is appropriate to the individual's mobility and activity level, with evidence described as Based on Tiers 1, 2, 3A evidence.

---

### Risk assessment and prevention of pressure ulcers: a clinical practice guideline from the American College of Physicians [^0b20daa2]. Annals of Internal Medicine (2015). Medium credibility.

Harms of interventions to prevent pressure ulcers — overall, a total of 15 studies assessed harms, and although details on specific harms were sparse, no serious treatment-related harms were reported; evidence was insufficient to determine how harms vary by intervention type, setting, or patient characteristics. Device-specific findings included heat-related discomfort reported in 3 trials of sheepskin overlays leading to withdrawals, one trial reporting differences in pain and sleep disturbances between dynamic mattresses, and a comparison of a multicell pulsating dynamic mattress with a static gel overlay that found no differences in risk for adverse events.

---

### Early blood pressure targets in acute spinal cord injury: a randomized clinical trial [^89881728]. JAMA Network Open (2025). High credibility.

Key Points

Question

Compared with conventional blood pressure, does early blood pressure augmentation improve long-term neurologic outcomes in acute spinal cord injury?

Findings

This multicenter randomized clinical trial of 92 patients with spinal cord injury did not find differences in 6-month motor or sensory scores between augmented and conventional blood pressures. The augmented blood pressure group had higher respiratory complications, longer mechanical ventilatory support, and worse organ dysfunction.

Meaning

These findings call into question the efficacy and safety of blood pressure augmentation due to higher complications without appreciable differences in neurologic function.

---

### Repositioning for preventing pressure injuries [^b32803bf]. NPIAP (2025). High credibility.

Repositioning to prevent pressure injuries in critically ill individuals — good practice statement and rationale: R9 states, "It is good practice to initiate frequent, small and incremental shifts (micromovements) in body position for critically ill individuals who are too unstable to maintain a regular repositioning regimen, and to supplement regular repositioning" and is labeled a "(Good practice statement)". Supporting context notes "We identified no comparative studies evaluating the effectiveness of micromovements versus usual care in critically ill individuals to inform an evidence-based recommendation regarding pressure injury outcomes", that "Full body repositioning is not always possible due to physiological instability, particularly in critical care settings", that "Frequent, small and incremental shifts (micromovements) in body weight can improve skin and tissue perfusion, and redistribute pressure", and that "Implementing frequent, small and incremental micromovements is feasible to offload or redistribute pressure as much as possible when regular repositioning is not clinically feasible".

---

### Pressure relieving support surfaces for pressure ulcer prevention (PRESSURE 2): clinical and health economic results of a randomised controlled trial [^c344aad9]. EClinicalMedicine (2019). Medium credibility.

2.3 Randomisation and Masking

Participants were randomised centrally (24 h automated telephone system, ensuring allocation concealment) on a 1:1 basis using minimisation (with random element) and minimisation factors: centre, PU status, type of facility, and type of consent. Following randomisation the patient was expected to be transferred to the allocated mattress within 24 h. Full details of randomisation and allocation procedures are given in eDocument 4.

Blinding of the research and clinical staff or patients was not possible due to the appearance of the mattresses. Assessment of risk of bias of the primary endpoint was done with central blind review of photographs and a 10% sample of patients who had skin assessments by a practitioner blinded to previous assessments was performed. Details of methods are provided elsewhere.

---

### Effect of a continuous bedside pressure mapping system for reducing interface pressures: a randomized clinical trial [^8c3e3c2d]. JAMA Network Open (2023). High credibility.

Outcomes

The primary outcomes for efficacy assessment were differences between the 2 groups in interface pressures. The pressure measures of interest were: (1) the absolute count of sensels with pressure readings greater than 40 mm Hg; (2) the mean interface pressure across all sensels under the participant's body (excluding sensels with 0 mm Hg reading); and (3) the proportion of participants who had pressure readings greater than 40 mm Hg. An average pressure of 32 mm Hg was previously referenced as a pressure threshold for tissue damage, but this has not been well validated. A pressure threshold of 40 mm Hg was selected for this study based on analysis of pilot data that showed a pressure reading of 39.88 mm Hg at the 90th percentile of the distribution of the pressure measured by the ForeSite PT system.

Secondary outcomes consisted of pressure-related skin and soft tissue changes in areas at risk of PI determined on a skin assessment performed by the research nurse after 72 hours and PI risk assessment by Braden score done at baseline and after 72 hours of monitoring. PIs were graded according to the National Pressure Injury Advisory Panel Pressure Injury Stages.

Statistical Analysis

As per protocol,678 participants were enrolled in the trial in order to randomize 339 participants to each of the intervention and control groups. Sample size estimates for the primary outcome indicated a need for 308 participants in each of the groups with an additional 31 participants per group to allow for 10% attrition. This was based on an analysis of pilot data that showed a mean (SD) pressure of 136 (62) mm Hg and allows for the detection of a statistically significant 15% relative decrease in the count of sensels over 40 mm Hg (β, 0.2 [type II error rate]). Univariate statistics were used to summarize changes in pressure distribution as per the interface pressure feedback collected by the CBPM system. Where appropriate, t test, analysis of variance, χ 2, and/or Fisher exact tests were used for comparisons of the primary and secondary outcomes between the control and intervention groups. Standardized mean differences (SMD) were calculated to assess the magnitude and potential importance of any baseline differences in characteristics of the control and intervention groups. A sensitivity analysis was performed for the primary outcome using multiple linear regression, in which adjustment for selected variables, guided by the SMD was performed. SMD greater than 0.10 was used as a threshold to determine which variables would be included in this sensitivity analysis.

---

### Risk assessment and prevention of pressure ulcers: a clinical practice guideline from the American College of Physicians [^39f5c869]. Annals of Internal Medicine (2015). Medium credibility.

American College of Physicians guideline — avoidance of alternating-air devices: ACP recommends against using alternating-air mattresses or alternating-air overlays in patients who are at an increased risk of developing pressure ulcers. (Grade: weak recommendation, moderate-quality evidence).

---

### Repositioning for preventing pressure injuries [^1e77afe6]. NPIAP (2025). High credibility.

Repositioning to prevent pressure injuries — movement sensor systems: R15 states, We suggest that a sensor system that monitors the individual's movement could be used to assist in evaluating repositioning needs for individuals at risk of pressure injuries when resources permit. (Conditional recommendation, very low certainty of evidence). In a meta-analysis of three studies comparing a body-worn movement sensor versus no system, pressure injury (PI) occurrence was 0.7% versus 6.9%, RR 0.15, 95% CI 0.02 to 1.08, p = 0.06, relative effect of 58 fewer PIs per 1,000 individuals treated [from 67 fewer to 5 more], with studies conducted in critical care and aged care settings; however, there is very little confidence that this effect estimate represents a true effect and the evidence was downgraded due to risk of bias, inconsistency, indirectness and imprecision. A decision analytic model found the patient wearable sensor was found to be cost-saving, assuming better clinical outcomes (77% reduction in HAPIs) and an expected cost savings of USD 6,621 per patient over a one-year period, though a 77% reduction in HAPIs may not be realistic in all settings.

---

### Prevention and treatment of pressure ulcers / injuries: quick reference guide prevention recommendations (fourth edition) [^7c4c3dd5]. NPIAP (2025). High credibility.

Pressure injuries — prevention bundles include a clinical question about the impact of a pressure injury prevention care bundle with at least three components on the number of individuals who develop a new pressure injury compared to usual care for at-risk individuals.

---

### Pressure relieving support surfaces for pressure ulcer prevention (PRESSURE 2): clinical and health economic results of a randomised controlled trial [^87f58c6e]. EClinicalMedicine (2019). Medium credibility.

2.4 Procedures

Patients were allocated to APM or HSF mattress for a maximum 60 day treatment phase (or until discharge, or no longer at risk), in conjunction with electric profiling bed frames. Treatment follow-up was twice weekly to day 30 and weekly from day 31–60 and there was a post treatment 30 day final follow-up.

Mattress specifications were defined (eDocument 1) and utilised from usual hospital supplies, maximising generalisability.

Participant recruitment and assessments were conducted by trained dedicated Clinical Research Nurse/Practitioners (CRN/P), employed by the local centre and independent of the ward teams. The assessment schedule was as follows:

Baseline only: risk factors were recorded using the PU Minimum Data Set.

Baseline and follow-up visits: a) skin status, assessed on 14 anatomical sites including PU classification, additional descriptors of alterations to intact skin and skin site exclusions (Table 1 and eDocument 6)and pain, b) PU prevention measures (e.g. repositioning frequency) and c) expected adverse events/serious adverse events (AEs/SAEs) including death, hospital re-admission, device-related ulcers and falls and 'related' and 'unexpected' SAEs (RUSAEs).

Table 1
Additional skin classifications.

Daily: mattress compliance (including which mattress the patient was on and whether, if it had dual function, it was in APM mode) was recorded during the treatment phase.

Baseline, week 1, week 3 and post treatment 30 day final follow-up: a generic QOL instrument EuroQol-5Dimension-5 Level (EQ-5D-5 L)and condition specific utility measure Pressure Ulcer-Quality of Life-Utility Index (PU-QOL-UI), were researcher administered with a healthcare resource utilisation questionnaire (combining healthcare records and patient reported sources).

---

### Improved lung recruitment and oxygenation during mandatory ventilation with a new expiratory ventilation assistance device: a controlled interventional trial in healthy pigs [^33140ec2]. European Journal of Anaesthesiology (2018). Low credibility.

A different way to elevate m P trach is to shorten the expiratory time, which could even result in inverse ratio ventilation. However, an increased I: E ratio yields the risk of incomplete expirationand is suspected of aggravating ventilator-induced lung injury.EVA ventilation, however, is based on direct measurement of P trach and switches from inspiration to expiration if PIP is achieved and from expiration to inspiration if PEEP is achieved. Thus, by its mere controlling principle, incomplete expiration or negative pressure development should be excluded.

The oxygenation increase of 10% in our study might be considered rather small; it is attributed to the limited recruitable lung volume in the healthy lungs of our animals. Quantitative CT scan techniques for lung imaging are well known and are usually performed as static measurements either at the end of inspiration or the end of expiration. – Due to its dynamic nature, intratidal derecruitment might be missed in such static analyses. Our analyses of dynamic sequences revealed an increased fraction of normally aerated and a decreased fraction of poorly aerated lung tissue during EVA ventilation. This can be explained by the shorter time alveolar pressure spends below the closing pressure due to the delayed pressure decrease during expiration. As derecruitment is a matter of seconds, we conclude that the EVA mode may result in a diminished intratidal derecruitment. This is in accord with the observed elevated m P trach and the improved oxygenation in the EVA group.

Histopathology revealed no signs of lung injury or tissue inflammation. As the investigated animals had healthy lungs and both groups were subjected to moderate P aw and V T, development of ventilator-induced lung injury after 5 h of mechanical ventilation seems very unlikely. Consequently, no conclusions can be drawn from this study concerning a direct lung protective effect of the EVA mode. To address these questions, more studies in specific situations like abdominal surgery or acute lung injury are needed.

---

### Routine intracranial pressure monitoring in acute coma [^9d130766]. The Cochrane Database of Systematic Reviews (2015). Low credibility.

Background

We know that the brain damage resulting from traumatic and other insults is not due solely to the direct consequences of the primary injury. A significant and potentially preventable contribution to the overall morbidity arises from secondary hypoxic-ischaemic damage. Brain swelling accompanied by raised intracranial pressure (ICP) prevents adequate cerebral perfusion with well-oxygenated blood. Detection of raised ICP could be useful in alerting clinicians to the need to improve cerebral perfusion, with consequent reductions in brain injury.

Objectives

To determine whether routine ICP monitoring in severe coma of any cause reduces the risk of all-cause mortality or severe disability at final follow-up.

Search Methods

We searched the Cochrane Injuries Group Specialised Register, the Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE (OvidSP), EMBASE (OvidSP), CINAHL Plus, ISI Web of Science (SCI-EXPANDED & CPCI-S), clinical trials registries and reference lists. We ran the most recent search on 22 May 2015.

Selection Criteria

All randomised controlled studies of real-time ICP monitoring by invasive or semi-invasive means in acute coma (traumatic or non-traumatic aetiology) versus clinical care without ICP monitoring (that is, guided only by clinical or radiological inference of the presence of raised ICP).

Data Collection and Analysis

Two authors (ET and RF) worked independently to identify the one study that met inclusion criteria. JR and RF independently extracted data and assessed risk of bias. We contacted study authors for additional information, including details of methods and outcome data.

Main Results

One randomized controlled trial (RCT) meeting the selection criteria has been identified to date. The included study had 324 participants. We judged risk of bias to be low for all categories except blinding of participants and personnel, which is not feasible for this intervention. There were few missing data, and we analysed all on an intention-to-treat basis. Participants could be 13 years of age or older (mean age of sample 29; range 22 to 44), and all had severe traumatic brain injury, mostly due to traffic incidents. All were receiving care within intensive care units (ICUs) at one of six hospitals in either Bolivia or Ecuador. Investigators followed up 92% of participants for six months or until death. The trial excluded patients with a Glasgow Coma Score (GCS) less than three and fixed dilated pupils on admission on the basis that they had sustained brain injury of an unsalvageable severity. The study compared people managed using either an intracranial monitor or non-invasive monitoring (imaging and clinical examination) to identify potentially harmful raised intracranial pressure. Both study groups used imaging and clinical examination measures. Mortality at six months was 56/144 (39%) in the ICP-monitored group and 67/153 (44%) in the non-invasive group. Unfavourable outcome (defined as death or moderate to severe disability at six months) as assessed by the extended Glasgow Outcome Scale (GOS-E) was 80/144 (56%) in the ICP-monitored group and 93/153 (61%) in the non-invasive group. Six percent of participants in the ICP monitoring group had complications related to the monitoring, none of which met criteria for being a serious adverse event. There were no complications relating to the non-invasive group. Other complications and adverse events were comparable between treatment groups, 70/157 (45%) in the ICP-monitored group and 76/167 (46%) in the non-invasive group. Late mortality in both the monitored and non-invasive groups was high, with 35% of deaths occurring > 14 days after injury. The authors comment that this high late mortality may reflect inadequacies in post-ICU services for disabled survivors requiring specialist rehabilitation care.

Authors' Conclusions

The data from the single RCT studying the role of routine ICP monitoring in acute traumatic coma fails to provide evidence to support the intervention. Research in this area is complicated by the fact that RCTs necessarily assess the combined impact of measurement of ICP with the clinical management decisions made in light of this data. Future studies will need to assess the added value of ICP data alongside other information from the multimodal monitoring typically performed in intensive care unit settings. Additionally, even within traumatically acquired brain injury (TBI), there is great heterogeneity in mechanisms, distribution, location and magnitude of injury, and studies within more homogeneous subgroups are likely to be more informative.

---

### Prevention and treatment of pressure ulcers / injuries: quick reference guide prevention recommendations (fourth edition) [^8b09f019]. NPIAP (2025). High credibility.

Pressure injuries — scope note states that clinical questions will be further refined based on available research literature.

---

### Alternating pressure (active) air surfaces for preventing pressure ulcers [^0102a067]. The Cochrane Database of Systematic Reviews (2021). Medium credibility.

Assessment of reporting biases

We followed the systematic framework recommended by Page 2019 to assess risk of bias due to missing results (non‐reporting bias) in the meta‐analysis of pressure ulcer incidence data. To make an overall judgement about risk of bias due to missing results, we:

identified whether pressure ulcer incidence data were unavailable by comparing the details of outcomes in trials registers, protocols or statistical analysis plans, if available, with reported results. If the above information sources were unavailable, we compared outcomes in the conference abstracts or in the methods section of the publication, or both, with the reported results. If we found non‐reporting of study results, we then judged whether the non‐reporting was associated with the nature of findings by using the 'Outcome Reporting Bias In Trials' (ORBIT) system (Kirkham 2018);
assessed the influence of definitely missing pressure ulcer incidence data on meta‐analysis; and
assessed the likelihood of bias where a study had been conducted but not reported in any form. For this assessment, we considered whether the literature search was comprehensive and planned to produce a funnel plot for meta‐analysis for seeking more evidence about the extent of missing results, provided there were at least 10 included studies (Peters 2008; Salanti 2014).

However, we did not produce a funnel plot for any meta‐analysis because all analyses in this review had fewer than 10 included studies.

---

### Prevention and treatment of pressure ulcers / injuries: quick reference guide prevention recommendations (fourth edition) [^424ed06e]. NPIAP (2025). High credibility.

Preventing pressure injuries in seated individuals — Good practice S4: It is good practice to frequently reposition individuals at risk of pressure injuries who are seated out of bed, and to teach and encourage independent chair/wheelchair users to reposition as often as possible by performing pressure redistribution maneuvers and weight shifts that redistribute pressure as much as possible; this is supported by indirect evidence & clinical expertise.

---

### Preventing pressure injuries among patients in the intensive care unit: insights gained [^888cc009]. Intensive Care Medicine (2022). Medium credibility.

Why, in the first quarter of the twenty-first century, do pressure injuries (PIs) remain a perennial problem for patients admitted in the intensive care unit (ICU)? PIs are associated with substantial morbidity, thereby burdening the patient and the healthcare system through pain, emotional distress, recovery, and prolonged hospitalization. ICU patients have one of the highest incidence and prevalence rates of PI as they often combine a high index of acute illness with underlying conditions (e.g. chronic obstructive pulmonary disease) facilitating skin breakdown. ICU patients have a nearly fourfold higher risk for hospital-acquired PI compared to non-ICU patients. International data from 1117 ICUs in 90 countries highlighted an ICU-acquired PI prevalence of 16.2% (95% confidence interval [CI] 15.6–16.8). Compared with countries with a high-income economy, the prevalence of ICU-acquired PIs appears higher in low- and lower–middle-income economies (odds ratio 1.8, 95% CI 1–3.3). Nearly one-third of all PI occur on the sacrum and heels. Device-related PIs accounts for up to 74% of all reported ICU-acquired PIs. Albeit that generic PI risk scores have demonstrated their value in non-ICU populations, prediction of ICU-acquired PIs remains challenging because of variations in heterogeneity, and the determinative importance of local case-mix, and organizational factors. Anyhow, ICU-specific risk factors often include aspects of organ support such as vasopressor use, mechanical ventilation, and renal replacement therapy. Therefore, ICU patients represent a unique population where the risk for PIs is arguably different in many ways from other patient groups.

---

### Risk assessment and prevention of pressure ulcers: a clinical practice guideline from the American College of Physicians [^6f6c11b8]. Annals of Internal Medicine (2015). Medium credibility.

Table 5 — Interventions to facilitate implementation of pressure ulcer prevention protocols or guidelines — multicomponent electronic clinical decision-support system vs. provision of guideline showed no difference in incident stage 2 to 4 ulcers in 1 fair-quality study (1.8% vs. 2.1%; RR, 0.85 [CI, 0.23 to 3.10]).

---

### Pressure relieving support surfaces for pressure ulcer prevention (PRESSURE 2): clinical and health economic results of a randomised controlled trial [^a5eb23de]. EClinicalMedicine (2019). Medium credibility.

2 Methods

2.1 Study Design

This was designed as a multicentre, Phase III, open, prospective, double triangular group sequential, parallel group, randomised controlled trial (RCT), with two planned interim analyses providing the possibility of early stopping for either futility or inferiority. The trial protocol is publishedand summary methods detailed.

The trial, approved by Leeds West Research Ethics Committee (13/YH/0066), was monitored by an independent Trial Steering Committee (TSC) and Data Monitoring Committee (DMC).

2.2 Participants

The trial was promoted to centres through national networks and any organisation with sufficient access to trial eligible mattresses (see eDocument 1) and electric profiling beds were able to take part in the trial.

Patients were recruited from adult secondary care and community in-patient acute admission facilities in the UK (facilities are defined in eDocument 2). Prior to recruitment patients could be laying on any type of mattress. Consent was obtained though written/witnessed verbal consent or consultee agreement (see eDocument 3).

Patients were eligible if they were: in-patient with evidence of acute illness; ≥ 8 years; expected stay ≥ 5 days; expected to comply with follow-up; on electric profiling bed-frame; high PU risk due to at least one of following:
a) Braden Activity score 1/2 AND Mobility score 1/2,
b) Category 1 PU
c) Localised skin pain on a healthy/altered/Category 1 pressure area.

Patients were excluded if they: had previously participated; current/previous PU Category ≥ 3; planned ICU admission; unable to receive intervention; outwith mattress weight limits (< 45 kg or > 180 Kg); ethically inappropriate e.g. thought to be in the last few days of their life.

Since a large proportion of patients suffering from or at risk of PUs have cognitive impairment and this impacts upon understanding and compliance with repositioning and self-care, including ability to reposition independently using the electric profiling beds, inclusion of patients who lacked capacity was necessary to ensure the study population was generalisable to a usual clinical population. Ethical approval was obtained to include patients who lacked capacity.

---

### Prevention and treatment of pressure ulcers / injuries: quick reference guide prevention recommendations (fourth edition) [^8467cf2a]. NPIAP (2025). High credibility.

Repositioning for preventing pressure injuries — micromovements good practice states It is good practice to initiate frequent, small and incremental shifts (micromovements) in body position for critically ill individuals who are too unstable to maintain a regular repositioning regimen, and to supplement regular repositioning, with the category listed as GPS and supported by indirect evidence and clinical expertise.

---

### Prevention and treatment of pressure ulcers / injuries: quick reference guide prevention recommendations (fourth edition) [^94a3087a]. NPIAP (2025). High credibility.

Repositioning for preventing pressure injuries — critically ill and end-of-life clarifiers states that critically ill individuals or others with systemic hypoperfusion or shock states may require more frequent, incremental repositioning and supplementation of full body repositioning with assisted small shifts in body position, and that individuals receiving palliative or end of life care should be given the option of repositioning frequency intervals that are best suited to their goals of care and comfort needs, with full knowledge of pressure injury risk incurred with less frequent repositioning.

---

### Pressure relieving support surfaces for pressure ulcer prevention (PRESSURE 2): clinical and health economic results of a randomised controlled trial [^4be763be]. EClinicalMedicine (2019). Medium credibility.

Funding

The National Institute for Health Research Health Technology Assessment programme. The views expressed in this presentation are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health.

---

### Nutrition in pressure injury prevention [^9d5daff0]. NPIAP (2025). High credibility.

Nutrition in pressure injury prevention implementation considerations state that tube feeding specifically for the purpose of preventing PIs should be considered very judiciously. Clinicians should Discuss the benefits and harms of implementing enteral (e.g., naso-enteric tube or PEG tube) or parenteral feeding with individuals at risk of PIs and their informal carers, Balance patient autonomy, beneficence, nonmaleficence, and justice, and note that Enteral feeding might be implemented for individuals who cannot meet their nutritional requirements through oral intake despite nutritional interventions when it meets their care goals and priorities. If used, enteral feeding should be administered by qualified professionals using a monitoring protocol that includes routine assessment that tube-feeding is delivered as prescribed, and The regimen should be guided by clinical guidance from nutrition/dietary guidelines appropriate to the individual's clinical, nutritional and demographic profile. Evaluate tolerance of enteral feeding daily through physical examinations, stool and flatus regularity, and gastrointestinal signs and symptoms, and Be aware of the risk of device related pressure injuries and mucosal membrane injuries when tube feeding is being administered; The guideline section Device Related Pressure Injuries discusses assessment and prevention strategies.

---

### Sustainable pressure injury prevention [^a6465029]. BMJ Open Quality (2023). High credibility.

Inclusion and exclusion criteria

Inclusion criteria included all individuals over the age of 18 years, identified as immobile at admission to the intensive care unit (ICU), assessed by quality team for bundle implementation within 2 hours of admission and had not passed away within 48 hours of admission. Exclusion criteria included individuals with PIs present on admission, pre-existing wounds over pressure points or extensive traumatic wounds. Patients who passed away within 48 hours of admission were not included in the study.

---

### Prevention and treatment of pressure ulcers / injuries: quick reference guide prevention recommendations (fourth edition) [^cc6e9b6e]. NPIAP (2025). High credibility.

Repositioning for preventing pressure injuries — good practice statements specify that it is good practice to reposition individuals at risk regardless of the type of pressure redistribution full body support surface being used, the interval between repositioning might be adjusted depending on the pressure redistribution capabilities of the support surface and the individual's response, and no support surface can entirely replace repositioning; it is good practice to reposition the individual to achieve optimal offloading of pressure points and maximum redistribution of pressure, and it is good practice to use specialized equipment, with certainty of evidence noted as Supported by Tier 3 evidence.

---

### Effect of a continuous bedside pressure mapping system for reducing interface pressures: a randomized clinical trial [^9bd2d76b]. JAMA Network Open (2023). High credibility.

Methods

Trial Design

Our hypothesis was that the use of CBPM technology by health care clinicians of patients at high risk of high interface pressures and PI development would decrease these risks. A parallel, 2-group randomized clinical trial (RCT) was conducted at a tertiary acute care center of approximately 1100 beds. Patients at high risk of PI development were recruited from acute general medical, neurology/stroke, neurosurgery, nephrology, and intensive care units (ICU). The primary outcome measures were interface pressures. Secondary measures reported here were pressure-related skin and soft tissue changes (eg, pressure injuries). Participants were randomly assigned to either the intervention or control groups in a ratio of 1:1 stratified by unit. The Research Electronic Data Capture (REDCap) secure database web application hosted at the University of Calgary was used for data storage. Participants were then to be monitored for at least 72 hours. The duration of monitoring was the estimated minimum length of time required to capture the development of PIs in study participants.

Both groups had the CPBM systems placed on their hospital bed to capture interface pressure data. Standard care for PI prevention was provided to both groups. In the intervention group, the monitor was turned on so health care clinicians caring for the participant could visualize the pressure data and target areas of the body requiring pressure relief. The CPBM systems were monitored daily to ensure that they were working. A brief 5-minute educational session was provided to nursing staff 1 to 2 months prior to the initiation of recruitment on the features of the CPBM system and how the data presented on the monitor could be used to reposition patients. Complete information on study design and methods is provided in Wong et al, although a number of minor modifications to the protocol (Supplement 1) as presented were made that are described here.

This study was approved by the Conjoint Health Research Ethics Board at the University of Calgary prior to data collection. Written informed consent was obtained from all study participants (or legal proxies). This study followed the Consolidated Standards of Reporting Trials reporting guideline for randomized clinical trials.

---

### Support surfaces for pressure ulcer prevention [^dd46944c]. The Cochrane Database of Systematic Reviews (2015). Low credibility.

Background

Pressure ulcers (i.e. bedsores, pressure sores, pressure injuries, decubitus ulcers) are areas of localised damage to the skin and underlying tissue. They are common in the elderly and immobile, and costly in financial and human terms. Pressure-relieving support surfaces (i.e. beds, mattresses, seat cushions etc) are used to help prevent ulcer development.

Objectives

This systematic review seeks to establish:(1) the extent to which pressure-relieving support surfaces reduce the incidence of pressure ulcers compared with standard support surfaces, and,(2) their comparative effectiveness in ulcer prevention.

Search Methods

In April 2015, for this fourth update we searched The Cochrane Wounds Group Specialised Register (searched 15 April 2015) which includes the results of regular searches of MEDLINE, EMBASE and CINAHL and The Cochrane Central Register of Controlled Trials (CENTRAL) (The Cochrane Library 2015, Issue 3).

Selection Criteria

Randomised controlled trials (RCTs) and quasi-randomised trials, published or unpublished, that assessed the effects of any support surface for prevention of pressure ulcers, in any patient group or setting which measured pressure ulcer incidence. Trials reporting only proxy outcomes (e.g. interface pressure) were excluded. Two review authors independently selected trials.

Data Collection and Analysis

Data were extracted by one review author and checked by another. Where appropriate, estimates from similar trials were pooled for meta-analysis.

Main Results

For this fourth update six new trials were included, bringing the total of included trials to 59. Foam alternatives to standard hospital foam mattresses reduce the incidence of pressure ulcers in people at risk (RR 0.40 95% CI 0.21 to 0.74). The relative merits of alternating- and constant low-pressure devices are unclear. One high-quality trial suggested that alternating-pressure mattresses may be more cost effective than alternating-pressure overlays in a UK context. Pressure-relieving overlays on the operating table reduce postoperative pressure ulcer incidence, although two trials indicated that foam overlays caused adverse skin changes. Meta-analysis of three trials suggest that Australian standard medical sheepskins prevent pressure ulcers (RR 0.56 95% CI 0.32 to 0.97).

Authors' Conclusions

People at high risk of developing pressure ulcers should use higher-specification foam mattresses rather than standard hospital foam mattresses. The relative merits of higher-specification constant low-pressure and alternating-pressure support surfaces for preventing pressure ulcers are unclear, but alternating-pressure mattresses may be more cost effective than alternating-pressure overlays in a UK context. Medical grade sheepskins are associated with a decrease in pressure ulcer development. Organisations might consider the use of some forms of pressure relief for high risk patients in the operating theatre.

---

### Repositioning for preventing pressure injuries [^1db9d2f6]. NPIAP (2025). High credibility.

Prone positioning in critical care — Prone position promotes gas exchange and improves lung function, reducing the requirement for ventilator support, but in these situations the ability to implement major repositioning may be limited and there is an increased risk of pressure injury on the anterior surface; the use of medical devices contributes to pressure injury risk, and small, incremental shifts (micromovements) may be the only opportunity to slightly offload areas at risk.

---

### Pressure-controlled versus volume-controlled ventilation for acute respiratory failure due to acute lung injury (ALI) or acute respiratory distress syndrome (ARDS) [^744b94b9]. The Cochrane Database of Systematic Reviews (2015). Low credibility.

Background

Acute lung injury (ALI) and acute respiratory distress syndrome (ARDS) account for one-quarter of cases of acute respiratory failure in intensive care units (ICUs). A third to half of patients will die in the ICU, in hospital or during follow-up. Mechanical ventilation of people with ALI/ARDS allows time for the lungs to heal, but ventilation is invasive and can result in lung injury. It is uncertain whether ventilator-related injury would be reduced if pressure delivered by the ventilator with each breath is controlled, or whether the volume of air delivered by each breath is limited.

Objectives

To compare pressure-controlled ventilation (PCV) versus volume-controlled ventilation (VCV) in adults with ALI/ARDS to determine whether PCV reduces in-hospital mortality and morbidity in intubated and ventilated adults.

Search Methods

In October 2014, we searched the Cochrane Central Register of Controlled Trials (CENTRAL) (2014, Isssue 9), MEDLINE (1950 to 1 October 2014), EMBASE (1980 to 1 October 2014), the Latin American Caribbean Health Sciences Literature (LILACS) (1994 to 1 October 2014) and Science Citation Index-Expanded (SCI-EXPANDED) at the Institute for Scientific Information (ISI) Web of Science (1990 to 1 October 2014), as well as regional databases, clinical trials registries, conference proceedings and reference lists.

Selection Criteria

Randomized controlled trials (RCTs) and quasi-RCTs (irrespective of language or publication status) of adults with a diagnosis of acute respiratory failure or acute on chronic respiratory failure and fulfilling the criteria for ALI/ARDS as defined by the American-European Consensus Conference who were admitted to an ICU for invasive mechanical ventilation, comparing pressure-controlled or pressure-controlled inverse-ratio ventilation, or an equivalent pressure-controlled mode (PCV), versus volume-controlled ventilation, or an equivalent volume-controlled mode (VCV).

Data Collection and Analysis

Two review authors independently screened and selected trials, assessed risk of bias and extracted data. We sought clarification from trial authors when needed. We pooled risk ratios (RRs) for dichotomous data and mean differences (MDs) for continuous data with their 95% confidence intervals (CIs) using a random-effects model. We assessed overall evidence quality using the GRADE (Grades of Recommendation, Assessment, Development and Evaluation) approach.

Main Results

We included three RCTs that randomly assigned a total of 1089 participants recruited from 43 ICUs in Australia, Canada, Saudi Arabia, Spain and the USA. Risk of bias of the included studies was low. Only data for mortality and barotrauma could be combined in the meta-analysis. We downgraded the quality of evidence for the three mortality outcomes on the basis of serious imprecision around the effect estimates. For mortality in hospital, the RR with PCV compared with VCV was 0.83 (95% CI 0.67 to 1.02; three trials, 1089 participants; moderate-quality evidence), and for mortality in the ICU, the RR with PCV compared with VCV was 0.84 (95% CI 0.71 to 0.99; two trials, 1062 participants; moderate-quality evidence). One study provided no evidence of clear benefit with the ventilatory mode for mortality at 28 days (RR 0.88, 95% CI 0.73 to 1.06; 983 participants; moderate-quality evidence). The difference in effect on barotrauma between PCV and VCV was uncertain as the result of imprecision and different co-interventions used in the studies (RR 1.24, 95% CI 0.87 to 1.77; two trials, 1062 participants; low-quality evidence). Data from one trial with 983 participants for the mean duration of ventilation, and from another trial with 78 participants for the mean number of extrapulmonary organ failures that developed with PCV or VCV, were skewed. None of the trials reported on infection during ventilation or quality of life after discharge.

Authors' Conclusions

Currently available data from RCTs are insufficient to confirm or refute whether pressure-controlled or volume-controlled ventilation offers any advantage for people with acute respiratory failure due to acute lung injury or acute respiratory distress syndrome. More studies including a larger number of people given PCV and VCV may provide reliable evidence on which more firm conclusions can be based.

---

### Prevention and treatment of pressure ulcers / injuries: quick reference guide prevention recommendations (fourth edition) [^8649acdb]. NPIAP (2025). High credibility.

Preventing pressure injuries in seated individuals — Recommendation S2: We recommend using a seating support surface with pressure redistribution properties for individuals at risk of pressure injuries when in a seated position; this is a Strong recommendation and is based on Tiers 1, 2, 3A evidence.

---

### Repositioning for preventing pressure injuries [^56a3b4e5]. NPIAP (2025). High credibility.

Repositioning — Additional considerations for individuals who can self-reposition include encouraging those independent in bed mobility to sleep in a 20-degree to 40-degree side lying position if not contraindicated, and providing diagrams and written instructions to help achieve a 30-degree lateral position with regular evaluation and review of positioning effectiveness.

---

### Comparative effectiveness of intracranial pressure monitoring on 6-month outcomes of critically ill patients with traumatic brain injury [^1a575fd4]. JAMA Network Open (2023). High credibility.

Discussion

Although contradictory literature on the efficacy of ICP monitoring in sTBI provides the ideal setting for a large-scale RCT, performing such a study in high-income countries appears unworkable because ICP monitoring is widely perceived as an essential component of sTBI management. Additionally, ICP monitoring is not amenable to direct evaluation and can only be tested as part of a comprehensive protocol that includes the therapeutic options used in response to monitored values. Simultaneously evaluating multiple ICP-monitor–based protocols against a nonmonitored control would require a huge, highly complex RCT protocol, which might still not fully answer the question.

A productive way to explore the issue of ICP monitoring is to interrogate multicenter, prospective, observational studies explicitly conceived for this purpose, such as CREACTIVE. This approach has 3 important advantages. First, it allows for assessing the procedure's effectiveness in current clinical practice rather than its efficacy in highly controlled environments. Second, collecting data on the use of the numerous treatments for intracranial hypertension helps us understand how ICP monitoring modifies TBI care. Finally, we can study the epidemiology of the use of ICP monitoring. Such insights are critical to formulating clinically relevant research questions to direct future studies.

In this prospective, observational study conducted at 43 ICUs, only one-third of the patients meeting the Brain Trauma Foundation criteria were actually monitored, and the use of monitoring varied considerably across centers. These results reflect a high degree of uncertainty within the TBI-management community about the procedure. Although the mortality among monitored and nonmonitored patients was similar, the monitored group had significantly more patients with severe disability and fewer with good recovery at 6 months. Monitored patients also received significantly more medical interventions and surgery for epidural hematomas or intraparenchymal mass lesions (eg, contusions). Single-event surgical procedures likely mirror the use of monitoring to determine surgical indications for initially marginal lesions. In contrast, medical interventions reflect a complex interaction among ICP thresholds, choice of treatments, perceived and real underlying TBI pathophysiology, management protocols, and responses to such treatments. We observed a much higher therapeutic intensity level, longer ICU stays, and more respiratory and infectious complications in the monitored group.

---

### Prevention and treatment of pressure ulcers / injuries: quick reference guide prevention recommendations (fourth edition) [^180ff271]. NPIAP (2025). High credibility.

Full body support surfaces for prevention of pressure injuries — SS7: We suggest using either alternating pressure (active) air or air (reactive) full body support surfaces for individuals at risk of pressure injuries; category is Conditional recommendation, certainty of evidence is Very low (Based on Tiers 1, 2, 3A evidence), and strength of recommendation is ↑.

---

### AARC clinical practice guideline: patient-ventilator assessment [^164ec576]. Respiratory Care (2024). High credibility.

Cuff pressure targets and monitoring — trial data and measurement accuracy: Appropriate cuff pressure to reduce microaspiration and tracheal injury has been identified as 20–30 cm H2O; across 6 RCTs, tapered versus standard cuff shape showed no significant difference in hospital-acquired pneumonia (odds ratio 0.97 [95% CI 0.73–1.28], P = 0.81). Infrequent versus frequent (every 8 h) cuff pressure measurement produced similar ventilator-associated event (VAE) occurrence (5.8% vs 3.6%, P = 0.37) despite 336 versus 1,531 measurements, and palpation/minimal leak techniques are inaccurate when compared to analog or digital pressure manometers. In RCTs of continuous cuff pressure regulation versus measurements every 8 h, sample sizes included 142 (n = 73 vs n = 69), 597, and 434 (n = 216 vs n = 218), with no reduction in VAP rates (22% vs 29%, P = 0.44; 25% vs 23%, P = 0.53; 33.8% vs 29.4%, P = 0.71) and no benefit for microbiologically confirmed VAP, distribution of early or late onset VAP, causative microorganisms, proportion of intubated days without antimicrobials, rate of ICU discharge, cost of ICU LOS, cost of ICU antimicrobials, cost of hospital LOS, ICU mortality, or hospital mortality.

---

### Prevention and treatment of pressure ulcers / injuries: quick reference guide prevention recommendations (fourth edition) [^70524e70]. NPIAP (2025). High credibility.

Pressure injuries — risk assessment, planning, and implementation questions focus on identifying Good Practice Statement principles needed to guide risk assessment, assess the level of risk, and identify modifiable risk factors for prevention planning, as well as which implementation strategies are being successfully used to implement risk-based prevention plans.

---

### Support surfaces for pressure ulcer prevention [^e1e4cdb7]. The Cochrane Database of Systematic Reviews (2004). Low credibility.

Background

Pressure ulcers (also known as bedsores, pressure sores, decubitus ulcers) are areas of localised damage to the skin and underlying tissue due to pressure, shear or friction. They are common in the elderly and immobile and costly in financial and human terms. Pressure-relieving beds, mattresses and seat cushions are widely used as aids to prevention in both institutional and non-institutional settings.

Objectives

This systematic review seeks to answer the following questions: to what extent do pressure-relieving cushions, beds, mattress overlays and mattress replacements reduce the incidence of pressure ulcers compared with standard support surfaces? how effective are different pressure-relieving surfaces in preventing pressure ulcers, compared to one another?

Search Strategy

The Specialised Trials Register of the Cochrane Wounds Group (compiled from regular searches of many electronic databases including MEDLINE, CINAHL and EMBASE plus handsearching of specialist journals and conference proceedings) was searched up to January 2004, Issue 3, 2004 of the Cochrane Central Register of Controlled Trials was also searched. The reference sections of included studies were searched for further trials.

Selection Criteria

Randomised controlled trials (RCTs), published or unpublished, which assessed the effectiveness of beds, mattresses, mattress overlays, and seating cushions for the prevention of pressure ulcers, in any patient group, in any setting. RCTs were eligible for inclusion if they reported an objective, clinical outcome measure such as incidence and severity of new of pressure ulcers developed. Studies which only reported proxy outcome measures such as interface pressure were excluded.

Data Collection and Analysis

Trial data were extracted by one researcher and checked by a second. The results from each study are presented as relative risk for dichotomous variables. Where deemed appropriate, similar studies were pooled in a meta analysis.

Main Results

41 RCTs were included in the review. Foam alternatives to the standard hospital foam mattress can reduce the incidence of pressure ulcers in people at risk. The relative merits of alternating and constant low pressure devices, and of the different alternating pressure devices for pressure ulcer prevention are unclear. Pressure-relieving overlays on the operating table have been shown to reduce postoperative pressure ulcer incidence, although one study indicated that an overlay resulted in adverse skin changes. One trial indicated that Australian standard medical sheepskins prevented pressure ulcers. There is insufficient evidence to draw conclusions on the value of seat cushions, limb protectors and various constant low pressure devices as pressure ulcer prevention strategies. A study of Accident & Emergency trolley overlays did not identify a reduction in pressure ulcer incidence. There are tentative indications that foot waffle heel elevators, a particular low air loss hydrotherapy mattress and an operating theatre overlay are harmful.

Reviewers' Conclusions

In people at high risk of pressure ulcer development, consideration should be given to the use of higher specification foam mattresses rather than standard hospital foam mattresses. The relative merits of higher-tech constant low pressure and alternating pressure for prevention are unclear. Organisations might consider the use of pressure relief for high risk patients in the operating theatre, as this is associated with a reduction in post-operative incidence of pressure ulcers. Seat cushions and overlays designed for use in Accident & Emergency settings have not been adequately evaluated.

---

### Dressings and topical agents for preventing pressure ulcers [^9fe67977]. The Cochrane Database of Systematic Reviews (2024). Medium credibility.

Methods

Criteria for considering studies for this review

Types of studies

Trials that randomised individuals (randomised controlled trials (RCTs)) or groups (cluster‐RCTs) were eligible for inclusion.

Types of participants

People of any age without a pressure ulcer, but considered to be at risk of developing a pressure ulcer, in any care setting.

Types of interventions

The intervention was any wound dressing or topical agent applied to the skin at any frequency with the aim of preventing the development of a pressure ulcer. We included studies comparing the use of dressings, topical agents, or topical agents with dressings, compared with a different dressing, topical agent, combined topical agent and dressing, no intervention or standard care, or any other intervention.

Types of outcome measures

Primary outcomes

Pressure ulcer incidence (the proportion of people developing any new pressure ulcer(s) of any stage). For the purpose of this review, we defined a pressure ulcer as a localised injury to the skin, underlying tissue, or both, usually over a bony prominence, as a result of pressure, or pressure in combination with shear. This review included all stages of pressure ulcer damage, following the definition of the EPUAP/NPIAP/PPPIA 2019. We accepted trial authors' definitions of, and methods for measuring, pressure ulcer incidence. We extracted data from the longest follow‐up period reported in the individual studies.

Secondary outcomes

Stage of any new pressure ulcer(s)
Time to ulcer development
Anatomical location of pressure ulcer development
Costs of interventions
Quality of life, measured on a validated scale
Pain at dressing change, measured using a validated scale
Acceptability of the intervention (or satisfaction) with respect to patient comfort
Adverse events
Length of hospital stay

---

### Reactive air surfaces for preventing pressure ulcers [^bb4ef1c9]. The Cochrane Database of Systematic Reviews (2021). Medium credibility.

Assessment of reporting biases

We followed the systematic framework recommended by Page 2019 to assess risk of bias due to missing results (non‐reporting bias) in the meta‐analysis of pressure ulcer incidence data. To make an overall judgement about risk of bias due to missing results, we did the following.

Identified whether pressure ulcer incidence data were unavailable by comparing the details of outcomes in trials registers, protocols or statistical analysis plans (if available) with reported results. If the above information sources were unavailable, we compared outcomes in the conference abstracts or in the methods section of the publication, or both, with the reported results. If we found non‐reporting of study results, we then judged whether the non‐reporting was associated with the nature of findings by using the 'Outcome Reporting Bias In Trials' (ORBIT) system (Kirkham 2018).
Assessed the influence of definitely missing pressure ulcer incidence data on meta‐analysis.
Assessed the likelihood of bias where a study had been conducted but not reported in any form. For this assessment, we considered whether the literature search was comprehensive and planned to produce a funnel plot for meta‐analysis for seeking more evidence about the extent of missing results, provided there were at least 10 included studies (Peters 2008; Salanti 2014).

However, we did not produce a funnel plot for any meta‐analysis because all analyses in this review had fewer than 10 included studies.

---

### Risk assessment and prevention of pressure ulcers: a clinical practice guideline from the American College of Physicians [^255397dd]. Annals of Internal Medicine (2015). Medium credibility.

Evidence related to individual preventive interventions — many interventions were studied by only 1 trial each and pooling was not practical; static (moderate-quality evidence) and alternating-air (low-quality evidence) mattresses or overlays reduced pressure ulcer incidence compared with standard hospital mattresses, whereas evidence was mixed or showed no statistically significant difference for other support surfaces; low-quality evidence showed no difference in risk or mixed results for heel supports or boots, different wheelchair cushions, nutritional supplementation, various dressings, intraoperative warming, and various repositioning intervals; low-quality evidence also showed that a skin cream containing fatty acid and a skin cleanser other than soap decreased risk for pressure ulcers.

---

### Guidelines for the management of severe traumatic brain injury, fourth edition [^d1d85e59]. Neurosurgery (2017). Medium credibility.

Severe traumatic brain injury — CPP target thresholds evidence base comprises two Class 2 cohort studies, one Class 3 RCT, and 13 Class 3 cohort studies; the smaller, older RCT did not find a difference in neurological outcomes between 50 mm Hg vs. 70 mm Hg thresholds; the two Class 2 cohort studies both reported better outcomes with higher CPP but at different thresholds (60 mm Hg and 70 mm Hg); for this reason, the quality of evidence is considered low and the Level II B recommendation of a target CPP is not precise; a re-analysis of the RCT data identified an association between the negative effects also seen in the trial with the use of pressors; the other 12 Class 3 studies were variable in their designs and inconsistent in their results, and for this reason the quality of the body of evidence is low and the Level III recommendation is limited to stating that CPP below 50 should be avoided.

---

### Pressure relieving support surfaces for pressure ulcer prevention (PRESSURE 2): clinical and health economic results of a randomised controlled trial [^185ee48b]. EClinicalMedicine (2019). Medium credibility.

2.5 Outcomes

The primary outcome was time to developing a new PU Category ≥ 2 from randomisation to 30 days from the end of the treatment phase (maximum of 90 days).

Secondary outcomes (Clinical)
1 Time to developing a new PU Category ≥ 3 from randomisation to trial completion
2 Time to developing a new PU Category ≥ 1 from randomisation to trial completion
3 Time to healing of all pre-existing Category 2 PUs from randomisation to trial completion
4 Mattress change during the treatment phase
5 Adverse events

Secondary objectives (Health Economic)
1 Health related quality of life (QOL) using SF-12 and PU-QoL-P instruments
2 Incremental cost-effectiveness of APM compared to HSF from the perspective of the health and social care sectors using EQ-5D-5 L and health and social care resource utilisation questionnaire

PUs were classified using the 2009 National Pressure Ulcer Advisory Panel/European Pressure Ulcer Advisory Panel (NPUAP/EPUAP)system. In the absence of a PU, additional descriptors were recorded including 'healthy intact skin', alterations to intact skin (referred to as Category A for data recording purposes) and 'not applicable' as detailed in Table 1.

---

### An implantable system to restore hemodynamic stability after spinal cord injury [^af7571f6]. Nature Medicine (2025). Excellent credibility.

Together, consistent results obtained in a total of 14 participants in four clinical studies across three countries conducted at three independent clinical centers with independent clinical teams provide robust preliminary data on the safety and efficacy of EES applied over the hemodynamic hotspot to treat hemodynamic instability in people living with chronic SCI. Monitoring the effectiveness of this therapy in ecological settings will require new technologies suitable to monitor blood pressure regularly throughout the day and concomitantly to changes in postural orientation and ongoing activities of the patients. Because these technologies are not yet available, we were not able to assess the efficacy of EES during the daily activities of the participants. However, we anticipate that these new technologies will open the possibility of quantifying the usage and benefit of EES to reduce the incidence and severity of hypotensive complications in ecological settings. These findings thus establish a path forward to treat the underappreciated, treatment-resistant hypotensive complications due to SCI. Completing this path will require a pivotal device trial that evaluates the safety and efficacy of this therapy.

---

### Repositioning for preventing pressure injuries [^c0047b4b]. NPIAP (2025). High credibility.

Repositioning — head-of-bed elevation recommendation R11: We suggest that the head-of-bed elevation be maintained at 30-degrees or lower to prevent pressure injury occurrence; however, higher head-of-bed elevation may be required in some clinical situations (e.g. individuals at higher risk for aspiration). (Conditional recommendation, low certainty of evidence).

---

### Prevention and treatment of pressure ulcers / injuries: quick reference guide prevention recommendations (fourth edition) [^530e587b]. NPIAP (2025). High credibility.

Repositioning for preventing pressure injuries — head-of-bed elevation (R11) provides a conditional recommendation stating, We suggest that the head-of-bed elevation be maintained at 30-degrees or lower to prevent pressure injury occurrence; however, higher head-of-bed elevation may be required in some clinical situations (e.g. individuals at higher risk for aspiration), with certainty of evidence reported as Low Based on Tiers 1, 2, 3A evidence.

---

### Active negative pressure peritoneal therapy after abbreviated laparotomy: the intraperitoneal vacuum randomized controlled trial [^c1b2977d]. Annals of Surgery (2015). Low credibility.

Objective

To determine whether active negative pressure peritoneal therapy with the ABThera temporary abdominal closure device reduces systemic inflammation after abbreviated laparotomy.

Background

Excessive systemic inflammation after abdominal injury or intra-abdominal sepsis is associated with poor outcomes.

Methods

We conducted a single-center, randomized controlled trial. Forty-five adults with abdominal injury (46.7%) or intra-abdominal sepsis (52.3%) were randomly allocated to the ABThera (n = 23) or Barker's vacuum pack (n = 22). On study days 1, 2, 3, 7, and 28, blood and peritoneal fluid were collected. The primary endpoint was the difference in the plasma concentration of interleukin-6 (IL-6) 24 and 48 hours after temporary abdominal closure application.

Results

There was a significantly lower peritoneal fluid drainage from the ABThera at 48 hours after randomization. Despite this, there was no difference in plasma concentration of IL-6 at baseline versus 24 (P = 0.52) or 48 hours (P = 0.82) between the groups. There was also no significant intergroup difference in the plasma concentrations of IL-1β, -8, -10, or -12 p70 or tumor necrosis factor α between these time points. The cumulative incidence of primary fascial closure at 90 days was similar between groups (hazard ratio, 1.6; 95% confidence interval, 0.82–3.0; P = 0.17). However, 90-day mortality was improved in the ABThera group (hazard ratio, 0.32; 95% confidence interval, 0.11–0.93; P = 0.04).

Conclusions

This trial observed a survival difference between patients randomized to the ABThera versus Barker's vacuum pack that did not seem to be mediated by an improvement in peritoneal fluid drainage, fascial closure rates, or markers of systemic inflammation.

Trial Registration

ClinicalTrials.gov identifier NCT01355094.

---

### Risk assessment and prevention of pressure ulcers: a clinical practice guideline from the American College of Physicians [^da81435f]. Annals of Internal Medicine (2015). Medium credibility.

Table 5 — repositioning interventions versus usual care provide mixed results: repositioning at a 30-degree tilt every 3 h compared with usual care showed lower risk "(3.0% vs. 11.0%; RR, 0.27 [CI, 0.08 to 0.93]); 1 fair-quality study", whereas scheduling repositioning every 2, 3, or 4 h showed "(2.5% vs. 6% vs. 3.0%, respectively) (P = 0.68)". Another study reported "No difference in risk for pressure ulcers among various repositioning intervals", and small unscheduled shifts in body position had "No difference in pressure ulcer risk, but only 1 or 2 ulcers were reported in each study".

---

### Negative pressure wound therapy for surgical wounds healing by primary closure [^40fc57d6]. The Cochrane Database of Systematic Reviews (2020). Medium credibility.

Limitations in study design, implementation and reporting

We assessed risk of bias according to six domains: sequence generation, allocation concealment, blinding, selective outcome reporting, incomplete follow‐up, and other potential biases. Our assessments of the risk of bias for a number of these domains found that all but three of the included studies, Chaboyer 2014; Gillespie 2015; WHIST 2019a, showed limitations in study design and implementation or reporting of these, which have been reported elsewhere in the review (Figure 3). We had particular concern, where blinding of the intervention is difficult or impossible, that there was subsequent uncertainty about allocation concealment and blinding of outcome assessment. We assumed the risk of performance bias to be unclear unless there was information to the contrary and we did not downgrade for high risk of performance bias alone. We did downgrade for high risk of bias in all other domains including detection bias where a substantial number of studies had a high risk. A number of studies used non‐standard designs and it was not clear that these were adequately accounted for in the authors' analyses. Where this was the case, we did not include the studies in the meta‐analyses we conducted but reported them separately; this included several studies which adopted an intra‐individual (split‐body) approach analogous to the 'split‐mouth' design (Lesaffre 2009).

Another consideration was the involvement of industry in at least 23 (where reported) of the 44 included trials. Authors from the Karlakki 2013 trial disclosed conflicts of interest, with all benefiting from funding from the manufacturer of the NPWT device. There continues to be a concern with the issue of manufacturer sponsorship in studies of healthcare products. For example, a review of the effect of manufacturer involvement on studies of NPWT examined 24 studies where 19 had manufacturer involvement. Importantly, 18 of the 19 manufacturer‐funded studies showed a positive effect for the manufacturer's product, while one was "impartial" (Kairinos 2014).

Indirectness of evidence

There was no indirectness, as the participants, interventions, and outcomes in the included studies were within the scope of the published review protocol. However, the evidence may not be directly relevant to children undergoing surgery. The high proportion of the participants in particular surgical indications may also be considered in assessing the relevance of the review to a particular population, although we did not find evidence of statistical differences in the effect estimates between different types of surgery.

---

### Combined effects of targeted blood pressure, oxygenation, and duration of device-based fever prevention after out-of-hospital cardiac arrest on 1-year survival: post hoc analysis of a randomized controlled trial [^41b07d61]. Critical Care (2024). Medium credibility.

Background

Following out-of-hospital cardiac arrest, severe hypoxic-ischemic brain injury account for most fatalities in patients initially resuscitated but still comatose at hospital admission. In the post-resuscitation phase various treatment modalities have been proposed for improving outcomes.

The complex pattern of symptoms faced in the care of resuscitated cardiac arrest patients has been termed post-cardiac arrest syndrome (PCAS). This syndrome consists of four interacting components, namely the pathology that caused the cardiac arrest, the ischemia–reperfusion injury, as well as cardiac dysfunction, and cerebral dysfunction despite return of spontaneous circulation (ROSC).

Current guidelines provide multiple treatment recommendations for the post-resuscitation phase, based mainly on general principles of critical care as well as principles specific for patients with PCAS. These include recommendations for arterial blood pressure and oxygenation targets, and a recommendation for temperature control. However, little evidence exists to inform these guidelines.

The "Blood Pressure and Oxygenation Targets in Post Resuscitation Care" (BOX) trial investigated whether a low versus high blood pressure target, a restrictive versus liberal oxygenation target, and a shorter versus longer duration of device-based fever prevention in comatose patients could improve outcomes. No differences in rates of discharge from hospital with severe disability or dying from all causes at 90 days were found for either of the 3 interventions. However, even after hospital discharge, cardiac arrest survivors are at increased risk of adverse outcomes, and the long-term or combined effects of these interventions on all-cause mortality are unknown. Accordingly, long-term outcomes of cardiac arrest patients could provide a more robust assessment of possible treatment effects, as even subtle short-term effects, not dissectible in rates of mortality or unfavorable neurologic outcome in the early phase, could result in increased risk of long-term morbidity and mortality. Therefore, the objective of this study is to investigate the individual as well as combined effects of the 3 interventions on 1-year mortality rates.

---

### Dressings and topical agents for preventing pressure ulcers [^e96cd266]. The Cochrane Database of Systematic Reviews (2024). Medium credibility.

Secondary outcomes

Stage of any pressure ulcers

Analysis 2.2; Table 2

One trial (270 participants) reported stage of pressure ulcer (Eberhardt 2021).

Stage 1 pressure ulcer

Foam dressings may reduce stage 1 pressure ulcer incidence compared to film dressings, but the evidence is very uncertain (foam dressing group 33/135, 24.4%; film dressing group 59/135, 43.7%; RR 0.56, 95% CI 0.39 to 0.80; very low‐certainty evidence: downgraded twice for high risk of performance and detection bias, and once for imprecision due to a small sample size).

Stage 2 pressure ulcer

Foam dressings may have little to no effect on the incidence of stage 2 pressure ulcers compared to film dressings, but the evidence is very uncertain (foam dressing group 1/135, 0.7%; film dressing group 1/135, 0.7%; RR 1.00, 95% CI 0.06 to 15.82; very low‐certainty evidence: downgraded twice for high risk of performance and detection bias, and twice for imprecision due to a small sample size, a small number of events, and a very wide confidence interval which includes 1).

Deep tissue injury

Foam dressings may have little to no effect on the incidence of deep tissue injury compared to film dressings, but the evidence is very uncertain (foam dressing group 2/135, 1.5%; film dressing group 3/135, 2.2%; RR 0.67, 95% CI 0.11 to 3.93; very low‐certainty evidence: downgraded twice for high risk of performance and detection bias; downgraded twice for imprecision due to small sample size, a small number of events, and a very wide confidence interval which includes 1).

Remaining review outcomes

None of the studies included in this comparison reported any of our remaining secondary outcomes of interest (i.e. time to pressure ulcer development; anatomical location; cost of interventions; quality of life; pain at dressing change; acceptability/satisfaction; adverse events; length of hospital stay).

---

### Personalized positive end-expiratory pressure in spontaneously breathing patients with acute respiratory distress syndrome by simultaneous electrical impedance tomography and transpulmonary pressure monitoring: a randomized crossover trial [^83176175]. Intensive Care Medicine (2024). Medium credibility.

We compared the optimal PEEP EIT-∆PL level with the one selected by alternative methods that are related to respiratory drive (P0.1) and effort (ΔPocc) but do not require additional monitoring. We found some agreement, especially for the lowest P0.1 measured during the decremental PEEP trial, which provided an identical PEEP suggestion in 53% of patients and a PEEP level that differed by < 4 cmH 2 O in 80% of patients. This could be explained by the correlations described between P0.1 and mechanical properties of the lung, like collapse, end-expiratory transpulmonary pressure, lung compliance and dynamic stress, making it a valid clinical alternative to more advanced and expensive monitoring systems, for example in developing countries or during pandemics.

Our study has some limitations. First, we assessed the short-term physiologic benefits of PEEP EIT-∆PL but the impact on long-term clinical outcomes remains to be verified. Second, as the main outcome involved analysis of airway pressure waveforms, blinding the assessors to study interventions was not feasible. Third, esophageal pressure measurements represent a single average value of pleural pressure that, in reality, differs regionally, and this adds some imprecision to the calculation of pixel-level compliances. Fourth, EIT only visualizes a portion of the lungs and therefore yields only a partial assessment of tidal changes across patients with highly heterogeneous sub-phenotypes of ARDS. Fifth, the lower PEEP/FiO 2 table has been chosen because it corresponds more closely to PEEP levels set by clinicians in the real world. However, given higher average values for PEEP EIT-∆PL, it could be interesting to compare its effects also with the higher PEEP/FiO 2 table. Sixth, even though PEEP EIT-∆PL provided, on average, physiological benefits, it is important to note that some patients did not benefit from an improvement in lung and diaphragm protection. In these patients, inappropriate application of higher PEEP could lead to worsening lung injury and a positive fluid balance. This result further underlies the need for personalization through advanced respiratory monitoring and to select patients who could benefit most from the proposed approach. Seventh, we enrolled mostly ARDS patients with mild hypoxemia. However, oxygenation may not be a reliable marker of the severity of lung injury in these patients and, in fact, the range of recruitability in our population was like previous studies that included more severe patients undergoing controlled ventilation. Finally, a cross-over design was chosen to minimise the risk of observing the effects of sequential application of PEEP strategies, rather than the isolated effects of each individual PEEP. However, given the personalised nature of each strategy, with PEEP EIT-∆PL unpredictably being lower or higher than PEEP TABLE, this may have been an unnecessary methodological step.

---

### Prevention and treatment of pressure ulcers / injuries: quick reference guide prevention recommendations (fourth edition) [^f3733705]. NPIAP (2025). High credibility.

Repositioning for preventing pressure injuries — two conditional recommendations with very low certainty are provided. R15 states, "We suggest that a sensor system that monitors the individual's movement could be used to assist in evaluating repositioning needs for individuals at risk of pressure injuries when resources permit", categorized as "Conditional recommendation" with "Very low" certainty "Based on Tiers 1, 2, 3A evidence". R16 states, "We suggest that an early mobilization program be implemented in individuals at risk for pressure injuries based on the individual's activity tolerance", also a "Conditional recommendation" with "Very low" certainty "Based on Tiers 1, 2, 3A evidence".

---

### Pressure relieving support surfaces for pressure ulcer prevention (PRESSURE 2): clinical and health economic results of a randomised controlled trial [^222003f9]. EClinicalMedicine (2019). Medium credibility.

Background

Pressure ulcers (PUs) are complications of serious acute/chronic illness. Specialist mattresses used for prevention lack high quality effectiveness evidence. We aimed to compare clinical and cost effectiveness of 2 mattress types.

Methods

Multicentre, Phase III, open, prospective, parallel group, randomised controlled trial in 42 UK secondary/community in-patient facilities.2029 high risk (acutely ill, bedfast/chairfast and/or Category 1 PU/pain at PU site) adult in-patients were randomised (1:1, allocation concealment, minimisation with random element) factors including: centre, PU status, facility and consent type. Interventions were alternating pressure mattresses (APMs) or high specification foam (HSF) for maximum treatment phase 60 days. Primary outcome was time to development of new PU Category ≥ 2 from randomisation to 30 day post-treatment follow-up in intention-to treat population. Trial registration: ISRCTN 01151335.

Findings

Between August 2013 and November 2016, we randomised 2029 patients (1016 APMs: 1013 HSF) who developed 160(7.9%) PUs. There was insufficient evidence of a difference between groups for time to new PU Category ≥ 2 Fine and Gray Model Hazard Ratio HR = 0.76, 95%CI0.56–1.04); exact P = 0.0890; absolute difference 2%). There was a statistically significant difference in the treatment phase time to event sensitivity analysis, Fine and Gray model HR = 0.66, 95%CI, 0.46–0.93; exact P = 0.0176); 2.6% absolute difference). Economic analyses indicate that APM are cost-effective. There were no safety concerns.

Interpretation

In high risk (acutely ill, bedfast/chairfast/Category 1 PU/ pain on a PU site) in-patients, we found insufficient evidence of a difference in time to PU development at 30-day final follow-up, which may be related to a low event rate affecting trial power. APMs conferred a small treatment phase benefit. Patient preference, low PU incidence and small group differences suggests the need for improved targeting of APMs with decision making informed by patient preference/comfort/rehabilitation needs and the presence of potentially modifiable risk factors such as being completely immobile, nutritional deficits, lacking capacity and/or altered skin/Category1 PU.

---

### The International Society for Heart and Lung Transplantation / Heart Failure Society of America guideline on acute mechanical circulatory support [^731869b2]. The Journal of Heart and Lung Transplantation (2023). High credibility.

Nursing care during acute mechanical circulatory support (MCS) — Center-based acute MCS device training and device-specific competency assessment is recommended for all nursing and support staff. Patient monitoring and care include regular observation and documentation of MCS parameters; strict monitoring for signs of infection; regular monitoring for signs of limb ischemia via observation, pulse palpation, and/or Doppler examination; compartment syndrome surveillance with immediate surgical consultation if suspected compromise of the limb; ensuring adequate oxygenation by physical examination and arterial blood gases; scheduled and frequent monitoring of line positions and cannula sites with transparent dressings where possible; avoiding use of MCS lines for routine blood draws and limiting access to the circuit; commencing pressure injury prevention early; elevating the head of the bed at 15°–30° to minimize aspiration risk; implementing nutrition as soon as possible; and, as per mentioned guidelines, targeted temperature management may be indicated early after resuscitation of cardiac arrest in unresponsive patients, although a recent large randomized trial found targeted hypothermia did not lead to a lower incidence of death by 6 months compared with targeted normothermia.

---

### Repositioning for preventing pressure injuries [^02bdebe3]. NPIAP (2025). High credibility.

Repositioning implementation for critically ill or hemodynamically unstable individuals — operational guidance: Use directives include "Use frequent, small weight redistributions (micromovements) and repositioning devices (e.g., wedges, gel pads, fluidized positioners and pillows) to offload pressure when regular full body repositioning is not possible" and "Micromovements do not replace the selection of a more appropriate pressure redistribution full body support surface when needed, or regular full body repositioning". Monitoring and tolerance guidance states "Evaluate hemodynamic and oxygenation status stabilization when moving the body. Allow at least ten minutes to attain equilibrium before determining whether the position change is tolerated. Revise the repositioning regimen in response to the individual's tolerance". For patients who cannot tolerate turns, it advises "In critically ill individuals who cannot tolerate slow, incremental turns, consider using frequent, small weight redistributions (micromovements), passive range of motion (ROM), repositioning the extremities, head rotation, heel elevation and tilting the body to lower angles. Select interventions based on individual tolerance". For unstable patients, it instructs "In hemodynamically unstable individuals, perform a trial of full body repositioning at least every eight hours (unless clinically contraindicated e.g., in unstable spinal cord injury) to determine if a regular repositioning regimen can be re-established. Resume regular full body repositioning as soon as the individual's hemodynamic and oxygenation status stabilize". Ongoing care includes "Regularly inspect pressure points and respond to signs of pressure damage by increasing the frequency of micromovements" and "Ensure the individual's head is offloaded with regular repositioning and micromovements if they are sedated and ventilated, where it is safe to do so. Repositioning devices can be used to support the head".

---

### Support surfaces for pressure ulcer prevention [^1eff96d7]. The Cochrane Database of Systematic Reviews (2011). Low credibility.

Background

Pressure ulcers (i.e. bedsores, pressure sores, decubitus ulcers) are areas of localised damage to the skin and underlying tissue. They are common in the elderly and immobile, and costly in financial and human terms. Pressure-relieving support surfaces (i.e. beds, mattresses, seat cushions etc) are used to help prevent ulcer development.

Objectives

This systematic review seeks to establish: (1) the extent to which pressure-relieving support surfaces reduce the incidence of pressure ulcers compared with standard support surfaces, and, (2) their comparative effectiveness in ulcer prevention.

Search Strategy

For this third update we searched: the Cochrane Wounds Group Specialised Register (searched 8 December 2010), The Cochrane Central Register of Controlled Trials (CENTRAL) (The Cochrane Library 2010, Issue 4); Ovid MEDLINE (1950 to November Week 3 2010); Ovid MEDLINE (In-Process & Other Non-Indexed Citations December 07, 2010); Ovid EMBASE (1980 to 2010 Week 48); EBSCO CINAHL (1982 to 3 December 2010), and the reference sections of included studies.

Selection Criteria

Randomised controlled trials (RCTs) and quasi-randomised studies, published or unpublished, that assessed the effects of any support surface for prevention of pressure ulcers, in any patient group or setting which measured pressure ulcer incidence. Studies reporting only proxy outcomes (e.g. interface pressure) were excluded. Two review authors independently selected studies.

Data Collection and Analysis

Data were extracted by one author and checked by another. Where appropriate, estimates from similar studies were pooled for meta-analysis.

Main Results

One new trial was included, bringing the total of included studies to 53. Foam alternatives to standard hospital foam mattresses reduce the incidence of pressure ulcers in people at risk (RR 0.40 95% CI 0.21 to 0.74). The relative merits of alternating- and constant low-pressure devices are unclear. One high-quality trial suggested that alternating-pressure mattresses may be more cost effective than alternating-pressure overlays in a UK context. Pressure-relieving overlays on the operating table reduce postoperative pressure ulcer incidence, although two studies indicated that foam overlays caused adverse skin changes. Meta-analysis of three trials indicated that Australian standard medical sheepskins prevent pressure ulcers (RR 0.56 95% CI 0.32 to 0.97).

Authors' Conclusions

People at high risk of developing pressure ulcers should use higher-specification foam mattresses rather than standard hospital foam mattresses. The relative merits of higher-specification constant low-pressure and alternating-pressure support surfaces for preventing pressure ulcers are unclear, but alternating-pressure mattresses may be more cost effective than alternating-pressure overlays in a UK context. Medical grade sheepskins are associated with a decrease in pressure ulcer development. Organisations might consider the use of some forms of pressure relief for high risk patients in the operating theatre.

---

### Alternating pressure (active) air surfaces for preventing pressure ulcers [^2e3fe384]. The Cochrane Database of Systematic Reviews (2021). Medium credibility.

Search methods for identification of studies

Electronic searches

We searched the following electronic databases to identify reports of relevant clinical trials:

the Cochrane Wounds Specialised Register (searched 14 November 2019);
the Cochrane Central Register of Controlled Trials (CENTRAL; 2019, Issue 10) in the Cochrane Library (searched 14 November 2019);
Ovid MEDLINE including In‐Process & Other Non‐Indexed Citations (1946 to 14 November 2019);
Ovid Embase (1974 to 14 November 2019);
EBSCO CINAHL Plus (Cumulative Index to Nursing and Allied Health Literature; 1937 to 14 November 2019).

The search strategies for the Cochrane Wounds Specialised Register, CENTRAL, Ovid MEDLINE, Ovid Embase and EBSCO CINAHL Plus can be found in Appendix 2. We combined the Ovid MEDLINE search with the Cochrane Highly Sensitive Search Strategy for identifying randomised trials in MEDLINE: sensitivity‐ and precision‐maximising version (2008 revision) (Lefebvre 2019). We combined the Embase search with the Ovid Embase filter developed by the UK Cochrane Centre (Lefebvre 2019). We combined the CINAHL Plus search with the trial filter developed by Glanville 2019. There were no restrictions with respect to language, date of publication or study setting.

We also searched the following clinical trials registries:

US National Institutes of Health Ongoing Trials Register ClinicalTrials.gov (searched 20 November 2019);
World Health Organization (WHO) International Clinical Trials Registry Platform (searched 20 November 2019).

Search strategies for clinical trial registries can be found in Appendix 2.

Searching other resources

For previous versions of McInnes 2015, the review authors of McInnes 2015 contacted experts in the field of wound care to enquire about potentially relevant, ongoing and recently published studies. In addition, the review authors of McInnes 2015 contacted manufacturers of support surfaces for details of any studies manufacturers were conducting. This approach did not yield any additional studies; therefore, we did not repeat it for this review.

We identified other potentially eligible studies or ancillary publications by searching the reference lists of retrieved included studies, as well as relevant systematic reviews, meta‐analyses and health technology assessment reports.

When necessary, we contacted authors of key papers and abstracts to request further information about their trials.

We did not perform a separate search for adverse effects of interventions used. We considered adverse effects described in included studies only.

---

### Repositioning for preventing pressure injuries [^990c97c0]. NPIAP (2025). High credibility.

Repositioning for preventing pressure injuries — implementation considerations: Consider an individual's positioning needs over a 24-hour period when developing a repositioning regimen, and check all pressure points when repositioning the individual to ensure that pressure has been adequately offloaded (i.e. Check that recently loaded pressure points are relieved of sustained pressure). Assess the individual's pain and comfort level before and after repositioning, evaluate the need for analgesia prior to repositioning, and when required, pre-medicate prior to assisting the individual with repositioning. Assess the individual's full body when repositioning, evaluate body alignment and posture to maximize comfort, support and pressure offloading, and use additional repositioning devices to provide comfort as required. Use positioning devices. These devices can assist in maintaining positioning, be used to elevate parts of the body off the support surface, and can promote body symmetry, posture and comfort; when placing a positioning device, take care that it is not positioned in a way that applies pressure to an anatomical area that is intended to be relieved of pressure, and consider using specialist repositioning devices to support the individual's specific needs/body shape. Check that no objects (e.g., mobile phone, cutlery, etc.) or medical devices are underneath the individual and, when repositioning individuals with medical devices, ensure the device is also appropriately repositioned to prevent device-related pressure and friction; areas such as the gluteal cleft, elbows, malleolus and wrists are vulnerable to PIs but are easily overlooked.

---

### Pressure ulcer prevention in intensive care-a randomised control trial of two pressure-relieving devices [^9df15f32]. Anaesthesia (2005). Low credibility.

Pressure sores are a potential complication of intensive care. Modern methods of pressure sore prevention centre around the use of pressure-relieving devices. Few studies exist that confirm the effectiveness of these devices. This study evaluates the effectiveness of two devices, the Hill-Rom Duo mattress and the KCI TheraPulse. High-risk patients were randomly assigned to receive one of two devices. We excluded those patients who had pressure sores upon admission. Those patients that did develop a pressure sore had their wound digitally photographed and graded by two independent tissue viability nurses. Sixty-two patients were included (30 TheraPulse, 32 Duo. Nine developed a pressure sore (6 Duo, 3 TheraPulse). No statistical differences between the two devices could be found. The longer a patient was nursed on a device, the greater the risk of pressure sore development. Despite the use of these devices, pressure sores can still develop in the Intensive Care patient population.

---

### Randomized clinical trial of negative pressure wound therapy as an adjunctive treatment for small-area thermal burns in children [^d666fa6b]. The British Journal of Surgery (2020). Medium credibility.

The 3‐ and 6‐month follow‐up results demonstrated modest improvements in scar outcomes with NPWT. There was a statistically significant reduction in only one measure, the difference in relative scar thickness at 3 months. Whether these assessments provided an accurate representation of hypertrophic scar formation in the cohort, however, is uncertain given several limiting factors. As with previous paediatric burn studies 45, the trial recorded low rates of long‐term follow‐up: only 15 per cent of participants attended both appointments. It also bears emphasis that the study predominantly involved superficial partial‐thickness burns with a TBSA of under 2 per cent, which are not in the highest risk category for hypertrophic scarring 6. Additional studies are needed to determine whether the beneficial effects of NPWT might translate to a more meaningful impact on scarring in children with larger, deeper burns.

The disadvantages of NPWT warrant consideration. Six children experienced minor periwound blistering or maceration, although these incidents did not appear to impair recovery. Of greater concern were the practical challenges. Clinical management of the NPWT apparatus was more laborious than that of standard dressings, with the creation and removal of an airtight seal often requiring the most time and effort. Some caregivers struggled with technical issues that led them to seek out‐of‐hours assistance, including visits to the emergency department. Air leaks in particular were a recurrent problem, especially in burns involving joints. Finally, the size and weight (1·2 kg) of the device rendered it physically onerous to very young patients. It is possible that ultraportable NPWT systems 46, 47 could provide the same therapeutic benefit with reduced burden.

A major strength of the present trial was its collection of validated patient‐centred endpoints. Many previous RCTs investigating NPWT 15, 16, 17 based their findings on surrogate outcomes, which tend to overestimate treatment effects 14.

In addition to the limitations already described, the 3–5‐day intervals between visits restricted the precision of the re‐epithelialization assessments. The nature of the intervention also precluded blinding of participants and clinicians, although the primary outcome was assessed by blinded review. Finally, despite eligibility criteria designed to be broadly inclusive, 57·9 per cent of patients who presented during the study period were ruled to be ineligible, principally owing to insufficient injury severity. Eligibility assessments may have been influenced by clinicians' perceptions of treatment burden, possibly constraining the generalizability of the trial's findings.

---

### Negative pressure wound therapy versus usual care in patients with surgical wound healing by secondary intention in the UK (SWHSI-2): an open-label, multicentre, parallel-group, randomised controlled trial [^6d25cd51]. Lancet (2025). Excellent credibility.

The study SWHSI-2 was published by Catherine Arundel and colleagues in 2025 in the journal Lancet. This study is related to the following diseases: Surgical site infection. In the SWHSI-2 study, the trial question was: what is the effect of negative pressure wound therapy in patients with lower limb surgical wound healing by secondary intention? In the SWHSI-2 study, the study design was: multi-center, open label, RCT. In the SWHSI-2 study, the population was: 686 patients (170 female, 516 male). The inclusion criteria were patients with a lower limb surgical wound healing by secondary intention. The key exclusion criteria were malnutrition; life expectancy < 6 months; active systemic infection; chronic or non-surgical wounds; risk of bleeding or inadequate hemostasis; contraindications to negative pressure wound therapy; participation in an ongoing wound care trial. In the SWHSI-2 study, the interventions were: n = 349 negative pressure wound therapy (negative pressure wound therapy applied to the wound in accordance with the manufacturer's guidance, application of 60–150 mmHg pressure) n = 337 usual care (routine wound care dressings without negative pressure wound therapy). In the SWHSI-2 study, the primary outcome was: no significant difference in time to wound healing (187 days vs. 195 days; HR 1.08, 95% CI 0.88 to 1.32). In the SWHSI-2 study, the secondary outcomes were: no significant difference in hospital admission (19.7% vs. 18.1%; OR 1.13, 95% CI 0.76 to 1.69) No significant difference in wound infection (31.9% vs. 31.2%; OR 1.05, 95% CI 0.75 to 1.48) No significant difference in antibiotic use (65.9% vs. 65.6%; OR 1.01, 95% CI 0.7 to 1.45). In the SWHSI-2 study, the safety outcomes were: no significant differences in adverse events, serious adverse events. In the SWHSI-2 study, the conclusion was: in patients with a lower limb surgical wound healing by secondary intention, negative pressure wound therapy was not superior to usual care with respect to time to wound healing.

---